Document_And_Entity_Informatio
Document And Entity Information (USD $) | 12 Months Ended | ||
Dec. 31, 2014 | Mar. 27, 2015 | Jun. 30, 2014 | |
Document Information [Line Items] | |||
Document Type | 10-K | ||
Amendment Flag | FALSE | ||
Document Period End Date | 31-Dec-14 | ||
Document Fiscal Year Focus | 2014 | ||
Document Fiscal Period Focus | FY | ||
Entity Registrant Name | 3DICON CORP | ||
Entity Central Index Key | 1375195 | ||
Current Fiscal Year End Date | -19 | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Filer Category | Smaller Reporting Company | ||
Entity Public Float | $3,438,716 | ||
Trading Symbol | TDCP | ||
Entity Common Stock, Shares Outstanding | 612,664,741 |
BALANCE_SHEETS
BALANCE SHEETS (USD $) | Dec. 31, 2014 | Dec. 31, 2013 |
Current assets: | ||
Cash | $34,485 | $70,769 |
Prepaid expenses | 17,149 | 13,919 |
Total current assets | 51,634 | 84,688 |
Deferred debt costs, net | 3,125 | 25,455 |
Deposits-other | 2,315 | 2,315 |
Total Assets | 57,074 | 112,458 |
Current liabilities: | ||
Current maturities of convertible notes and debentures payable | 405,791 | 612,744 |
Warrant exercise advances | 21,591 | 185,671 |
Accounts payable | 384,639 | 140,410 |
Accrued salaries | 158,102 | 1,713 |
Accrued interest on debentures | 36,777 | 22,751 |
Total current liabilities | 1,006,900 | 963,289 |
Total Liabilities | 1,006,900 | 963,289 |
Common stock subject to put rights and call right, 1,685,714 shares | 0 | 485,649 |
Stockholders' deficiency: | ||
Preferred stock, Series A convertible, $0.0002 par value, 500,000 shares authorized; 355,000 and 195,000 shares issued and outstanding at December 31, 2014 and December 31, 2013, respectively | 71 | 39 |
Common stock $0.0002 par, 1,500,000,000 shares authorized; 539,674,567 and 248,191,444 shares issued and outstanding at December 31, 2014 and December 31, 2013, respectively | 107,935 | 49,638 |
Additional paid-in capital | 20,200,743 | 18,618,714 |
Accumulated deficit | -21,258,575 | -20,004,871 |
Total Stockholders' Deficiency | -949,826 | -1,336,480 |
Total Liabilities and Stockholders' Deficiency | $57,074 | $112,458 |
BALANCE_SHEETS_Parenthetical
BALANCE SHEETS (Parenthetical) (USD $) | Dec. 31, 2014 | Dec. 31, 2013 |
Common stock subject to put rights and call right, shares | 1,685,714 | 1,685,714 |
Preferred Stock, Par or Stated Value Per Share | $0.00 | $0.00 |
Preferred Stock, Shares Authorized | 500,000 | 500,000 |
Preferred Stock, Shares Issued | 355,000 | 195,000 |
Preferred Stock, Shares Outstanding | 355,000 | 195,000 |
Common stock, par | $0.00 | $0.00 |
Common stock, shares authorized | 1,500,000,000 | 1,500,000,000 |
Common stock, shares issued | 539,674,567 | 248,191,444 |
Common stock, shares outstanding | 539,674,567 | 248,191,444 |
STATEMENTS_OF_OPERATIONS
STATEMENTS OF OPERATIONS (USD $) | 12 Months Ended | |
Dec. 31, 2014 | Dec. 31, 2013 | |
Income: | ||
Sales | $15,000 | $4,500 |
Grant income | 70,748 | 43,896 |
Total income | 85,748 | 48,396 |
Expenses: | ||
Research and development | 198,550 | 372,984 |
General and administrative | 1,065,167 | 1,077,106 |
Interest | 75,735 | 80,355 |
Total expenses | 1,339,452 | 1,530,445 |
Net loss | ($1,253,704) | ($1,482,049) |
Loss per share: | ||
Basic and diluted | ($0.00) | ($0.01) |
Weighted average shares outstanding, Basic and diluted | 394,420,243 | 105,435,660 |
STATEMENTS_OF_CHANGES_IN_STOCK
STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY DEFICIENCY (USD $) | Total | Stock issued for services | Stock issued for liabilities | Stock issued for cash | Warrants issued to purchase common stock | Preferred Stock | Preferred Stock | Preferred Stock | Preferred Stock | Preferred Stock | Common Stock | Common Stock | Common Stock | Common Stock | Common Stock | Additional Paid-In Capital | Additional Paid-In Capital | Additional Paid-In Capital | Additional Paid-In Capital | Additional Paid-In Capital | Accumulated Deficit During the Development Stage | Accumulated Deficit During the Development Stage | Accumulated Deficit During the Development Stage | Accumulated Deficit During the Development Stage | Accumulated Deficit During the Development Stage |
Stock issued for services | Stock issued for liabilities | Stock issued for cash | Warrants issued to purchase common stock | Stock issued for services | Stock issued for liabilities | Stock issued for cash | Warrants issued to purchase common stock | Stock issued for services | Stock issued for liabilities | Stock issued for cash | Warrants issued to purchase common stock | Stock issued for services | Stock issued for liabilities | Stock issued for cash | Warrants issued to purchase common stock | ||||||||||
Beginning Balance at Dec. 31, 2012 | ($1,468,849) | $0 | $9,187 | $17,044,786 | ($18,522,822) | ||||||||||||||||||||
Beginning Balance (in shares) at Dec. 31, 2012 | 0 | 45,934,839 | |||||||||||||||||||||||
Warrants and options exercised (in shares) | 0 | 0 | 1,103 | 0 | |||||||||||||||||||||
Warrants and options exercised | 420,740 | 30,000 | 0 | 0 | 1 | 0 | 420,739 | 30,000 | 0 | 0 | |||||||||||||||
Stock issued (in shares) | 0 | 0 | 195,000 | 25,892,479 | 1,098,751 | 0 | |||||||||||||||||||
Stock issued | 295,350 | 31,500 | 268,000 | 0 | 0 | 39 | 5,178 | 219 | 0 | 290,172 | 31,281 | 267,961 | 0 | 0 | 0 | ||||||||||
Debentures converted (in shares) | 0 | 175,264,242 | |||||||||||||||||||||||
Debentures converted | 568,828 | 0 | 35,053 | 533,775 | 0 | ||||||||||||||||||||
Net loss for the period | -1,482,049 | 0 | 0 | 0 | -1,482,049 | ||||||||||||||||||||
Ending Balance at Dec. 31, 2013 | -1,336,480 | 39 | 49,638 | 18,618,714 | -20,004,871 | ||||||||||||||||||||
Ending Balance (in shares) at Dec. 31, 2013 | 195,000 | 248,191,414 | |||||||||||||||||||||||
Warrants and options exercised (in shares) | 0 | 0 | 1,347 | 0 | |||||||||||||||||||||
Warrants and options exercised | 513,390 | 34,926 | 0 | 0 | 1 | 0 | 513,389 | 34,926 | 0 | 0 | |||||||||||||||
Stock issued (in shares) | 0 | 0 | 190,000 | 28,205,571 | 13,131,828 | 0 | |||||||||||||||||||
Stock issued | 108,500 | 6,267 | 155,074 | 0 | 0 | 38 | 5,641 | 2,626 | 0 | 102,859 | 3,641 | 155,036 | 0 | 0 | 0 | ||||||||||
Debentures converted (in shares) | 0 | 245,458,693 | |||||||||||||||||||||||
Debentures converted | 336,552 | 0 | 49,092 | 287,460 | 0 | ||||||||||||||||||||
Preferred stock converted to common shares (in shares) | -30,000 | 3,000,000 | |||||||||||||||||||||||
Preferred stock converted to common shares | 0 | -6 | 600 | -594 | 0 | ||||||||||||||||||||
Shares subject to expired put calls restored (in shares) | 0 | 1,685,714 | |||||||||||||||||||||||
Shares subject to expired put calls restored | 485,649 | 0 | 337 | 485,312 | 0 | ||||||||||||||||||||
Net loss for the period | -1,253,704 | 0 | 0 | 0 | -1,253,704 | ||||||||||||||||||||
Ending Balance at Dec. 31, 2014 | ($949,826) | $71 | $107,935 | $20,200,743 | ($21,258,575) | ||||||||||||||||||||
Ending Balance (in shares) at Dec. 31, 2014 | 355,000 | 539,674,567 |
STATEMENTS_OF_CASH_FLOWS
STATEMENTS OF CASH FLOWS (USD $) | 12 Months Ended | |
Dec. 31, 2014 | Dec. 31, 2013 | |
Cash Flows from Operating Activities | ||
Net loss | ($1,253,704) | ($1,482,049) |
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Stock issued for services | 108,500 | 295,350 |
Amortization of debt issuance costs | 77,109 | 61,434 |
Depreciation | 0 | 4,280 |
Change in: | ||
Accounts receivable | 0 | 13,028 |
Prepaid expenses and other assets | -3,230 | -1,309 |
Accounts payable and accrued liabilities | 420,911 | 46,327 |
Net cash used in operating activities | -650,414 | -1,062,939 |
Cash Flows from Financing Activities | ||
Proceeds from stock and warrant sales, exercise of warrants and warrant exercise advances | 539,310 | 969,810 |
Proceeds from issuance of debentures, notes and options | 215,500 | 283,068 |
Cash paid on debentures | -140,680 | -120,520 |
Net cash provided by financing activities | 614,130 | 1,132,358 |
Net change in cash | -36,284 | 69,419 |
Cash, beginning of period | 70,769 | 1,350 |
Cash, end of period | 34,485 | 70,769 |
Non-Cash Investing and Financing Activities | ||
Conversion of debentures to common stock (net) | 336,552 | 568,828 |
Cash paid for interest | 11,928 | 21,145 |
Stock issued to satisfy payables | 6,267 | 31,500 |
Debenture issued to satisfy payable | $0 | $197,631 |
Organization_and_Operations
Organization and Operations | 12 Months Ended |
Dec. 31, 2014 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Organization and Operations | Note 1 – Organization and Operations |
Organization | |
3DIcon Corporation (the "Company") was incorporated on August 11, 1995, under the laws of the State of Oklahoma as First Keating Corporation. The articles of incorporation were amended August 1, 2003 to change the name to 3DIcon Corporation. The initial focus of First Keating Corporation was to market and distribute books written by its founder, Martin Keating. During 2001, First Keating Corporation began to focus on the development of 360-degree holographic technology. The effective date of this transition is January 1, 2001, and the financial information presented is from that date through the current period. The Company accounted for this transition as reorganization and accordingly, restated its capital accounts as of January 1, 2001. From January 1, 2001, the Company's primary activity has been the raising of capital in order to pursue its goal of becoming a significant participant in the development, commercialization and marketing of next generation 3D display technologies. | |
The mission of the Company is to develop (or acquire), commercialize, and market next generation 3D display technologies including auto-stereoscopic (glasses-free) volumetric 360-degree full-color 3D displays and possibly auto-stereoscopic (glasses-free) flat screen 3D displays. The Company’s initial market focus is on business, industrial, and government applications of the technologies. At this time the Company owns no intellectual property in 3D displays but does own the exclusive worldwide rights to commercial and government usage of the 3D display intellectual property developed by the University of Oklahoma. | |
Uncertainties | |
The accompanying financial statements have been prepared on a going concern basis. The Company is in the development stage and has insufficient revenue and capital commitments to fund the development of its planned product and to pay operating expenses. | |
The Company has realized a cumulative net loss of $21,258,575 for the period from inception (January 1, 2001) to December 31, 2014, and a net loss of $1,253,704 and $1,482,049 for the years ended December 31, 2014 and 2013, respectively. | |
The ability of the Company to continue as a going concern during the next year depends on the successful completion of the Company's capital raising efforts to fund the development of its planned technologies. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. | |
Management plans to fund the future operations of the Company with existing cash of $34,485, grants and investor funding. Under the terms of the Golden State 4.75% Convertible Debenture due on December 31, 2015 as a result of a maturity extension agreement received by the Company in March 2015, beginning in November 2007, Golden State is obligated to submit conversion notices in an amount such that Golden State receives 1% of the outstanding shares of the Company every calendar quarter for a period of one year. In connection with each conversion, Golden State is expected to simultaneously exercise a percentage of warrants equal to the percentage of the principal being converted. The warrants are exercisable at $381.50 per share. The number of warrants exercisable is subject to certain beneficial ownership limitations contained in the 4.75% Convertible Debenture (“the Beneficial Ownership Limitations”). The Beneficial Ownership Limitations prevent Golden State from converting on the 4.75% Convertible Debenture or exercising warrants if such conversion or exercise would cause Golden State’s holdings to exceed 9.99% of the Company’s issued and outstanding common stock. Subject to the Beneficial Ownership Limitations and provided that Golden State is able to sell the shares under Rule 144, Golden State is required to convert $85.71 of the 4.75% Convertible Debenture and exercise 857 warrants per month. Based upon the current stock price, the issued and outstanding shares as of December 31, 2014 and ignoring the impact of the Beneficial Ownership Limitations, the Company may receive up to $327,000 per month in funding from Golden State as a result of warrant exercises. Due to the Beneficial Ownership Limitations, the Company received $349,310 in advances from Golden State during the year ended December 31, 2014. Such advances are recorded within warrant exercise advances on the balance sheet when received. | |
On July 2, 2013, the Company was awarded a $300,000 grant in the 2013 Oklahoma Applied Research Support competition sponsored by the Oklahoma Center for the Advancement of Science and Technology (“OCAST”). The money is being used to support the development of the Company’s first Product Platform, which will be the basis for a family of products based on the Company’s CSpace® volumetric 3D display technology. (see Note 5) | |
As part of the Company’s federal funding strategy the Company intends to effectively compete by forming interdisciplinary teams with potential strategic partners (large and small), academic and commercial laboratories, and systems integrators providing integrated data visualization solutions. The first of these partnerships was reached in March 2014 when the Company signed a Joint Development Agreement with Schott Defense, a federally focused subsidiary of Schott North America. | |
Additionally, the Company is continuing to pursue financing through private offering of debt or common stock. | |
Summary_of_Significant_Account
Summary of Significant Accounting Policies | 12 Months Ended |
Dec. 31, 2014 | |
Accounting Policies [Abstract] | |
Significant Accounting Policies [Text Block] | Note 2 – Summary of Significant Accounting Policies |
Research and development | |
Research and development costs, including payments made to the University pursuant to the SRA, are expensed as incurred (see Note 4). | |
Stock-based compensation | |
The Company accounts for stock-based compensation arrangements for employees in accordance with Accounting Standards Codification ("ASC") No. 718, Compensation-Stock Compensation. The Company recognizes expenses for employee services received in exchange for stock based compensation based on the grant-date fair value of the shares awarded. The Company accounts for stock issued to non-employees in accordance with the provisions of ASC No. 718. | |
Income taxes | |
The Company accounts for income taxes in accordance with ASC No. 740, Income Taxes. This standard requires the recognition of deferred tax assets and liabilities for the estimated future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. In addition, this standard requires the recognition of future tax benefits, such as net operating loss carry forwards, to the extent that realization of such benefits is more likely than not. The amount of deferred tax liabilities or assets is calculated using tax rates in effect for the year in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rate is recognized in income in the period that includes the enactment date. Valuation allowances are established when necessary to reduce deferred tax assets to the amounts more likely than not to be realized. | |
Net loss per common share | |
The Company computes net loss per share in accordance with ASC No. 260, Earnings Per Share. Under the provisions of this standard, basic net loss per common share is based on the weighted-average outstanding common shares. Diluted net loss per common share is based on the weighted-average outstanding shares adjusted for the dilutive effect of warrants to purchase common stock and convertible debentures. Due to the Company's losses, such potentially dilutive securities are anti-dilutive for all periods presented. The weighted average number of potentially dilutive shares is 42,819,990 and 33,321,337 for the years ended December 31, 2014 and 2013, respectively. | |
Use of estimates | |
The preparation of financial statements in conformity with U. S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and the disclosure of contingent assets and liabilities. Actual results could differ from the estimates and assumptions used. | |
Debt issue costs | |
The Company defers and amortizes the legal and filing fees associated with long-term debt that is issued. These costs are primarily related to the convertible debentures, the majority of which have a one year term. The amortization is charged to operations over the one year term and then adjusted quarterly for debenture conversions to common stock. | |
Fair value of financial instruments | |
The following methods and assumptions were used to estimate the fair value of each class of financial instrument held by the Company: | |
Current assets and current liabilities – The carrying value approximates fair value due to the short maturity of these items. | |
Debentures payable – The fair value of the Company's debentures payable has been estimated by the Company based upon the liability's characteristics, including interest rate. The carrying value approximates fair value. | |
Recent_Accounting_Pronouncemen
Recent Accounting Pronouncements | 12 Months Ended |
Dec. 31, 2014 | |
New Accounting Pronouncements and Changes in Accounting Principles [Abstract] | |
Recent Accounting Pronouncements | Note 3 – Recent Accounting Pronouncements |
The following is a summary of recent accounting pronouncements that are relevant to the Company: | |
In June 2014, the FASB issued “Development Stage Entities – Elimination of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation” (“ASU 2014-10”). ASU 2014-10 eliminates the concept of a development stage entity, thereby eliminating the financial reporting distinction between development stage entities and other reporting entities. As a result of the elimination, certain financial reporting disclosures have been eliminated as well, including the presentation of inception-to-date information and the labeling of financial statements as those of a development stage entity. ASU 2014-10 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2014. Early adoption of this standard is permitted, and we adopted the standard as of July 1, 2014. Subsequent to the adoption of ASU 2014-10, the Company no longer presents inception-to-date information in the statements of operations, cash flows, and stockholders’ equity. | |
The FASB has issued ASU No. 2014-09, Revenue from Contracts with Customers. This ASU supersedes the revenue recognition requirements in FASB ASC 605 - Revenue Recognition and most industry-specific guidance throughout the Codification. The standard requires that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. This ASU is effective on January 1, 2017 and should be applied retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of initially applying the ASU recognized at the date of initial application. The adoption of this standard is not expected to have a material impact on the Company’s financial position and results of operations. | |
The FASB has issued ASU No. 2014-12, Compensation - Stock Compensation (ASC Topic 718): Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period. This ASU requires that a performance target that affects vesting, and that could be achieved after the requisite service period, be treated as a performance condition. As such, the performance target should not be reflected in estimating the grant date fair value of the award. This update further clarifies that compensation cost should be recognized in the period in which it becomes probable that the performance target will be achieved and should represent the compensation cost attributable to the period(s) for which the requisite service has already been rendered.. The amendments in this ASU are effective for annual periods and interim periods within those annual periods beginning after December 15, 2015. Earlier adoption is permitted. The adoption of this standard is not expected to have a material impact on the Company's financial position and results of operations. | |
Sponsored_Research_Agreement_S
Sponsored Research Agreement ("SRA") Common Stock Subject to Put Rights and Call Right | 12 Months Ended |
Dec. 31, 2014 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Sponsored Research Agreement ("SRA") Common Stock Subject to Put Right and Call Right | Note 4 – Sponsored Research Agreement ("SRA") Common Stock Subject to Put Rights and Call Right |
Since April 20, 2002, the Company has entered into a number of SRAs with the University of Oklahoma (“OU”) as follows: | |
Phase I: “Pilot Study to Investigate Digital Holography”, April 20, 2004. The Company paid the University $14,116. | |
Phase II: “Investigation of 3-Dimensional Display Technologies”, April 15, 2005, as amended. The Company paid the University $528,843. | |
Phase III: “3-Dimensional Display Development”. The Company made partial payment to the University by issuing 121,849 shares with a market price of $290,000 on October 14, 2008 and final payment on December 1, 2010 in the amount of $525,481 of which $40,481 was in cash and 1,685,714 shares of Company stock (the “Shares”). The Shares were subject to the University ‘put’ right and a 3Dicon ‘call’ right. | |
The University “Put” Rights on the Shares | |
First “put” period: December 1, 2012 to November 30, 2013. If the Shares (held plus previously sold) are valued at less than $100,000 then the University can “put” one-tenth of the Shares for $50,000 plus accrued interest retro-active to December 1, 2012 less the value of sold shares. The University currently holds 1,807,563 shares with a market value of less than $100,000. Under the terms of put rights, the put rights could be exercised by the University and the Company would be obligated to pay the University $50,000. | |
Second “put” period: December 1, 2013 to November 30, 2014. If the Shares (held & previously sold) are valued at less than $970,000 than the University can “put” the remaining Shares for $485,000 plus accrued interest retro-active to December 1, 2012 less the value of shares previously sold or redeemed during the first “put”. | |
The “put” periods expired without the University taking any action. The shares have therefore been restored to the equity section of the Balance Sheet as of December 31, 2014 as the shares are no longer subject to the put and call options. | |
3DIcon “Call” rights on the Shares | |
Commencing December 1, 2012, the Company shall have the right to “call” the Shares for an amount equal to $970,000 less the amount (if any) of prior shares by the University including amounts “put” to 3DIcon. | |
The Company has presented the shares outside of deficit in the mezzanine section of the balance sheets through November 30, 2014 as the Agreement includes put rights, which are not solely within the control of the Company. | |
The Agreement also amended the existing agreements between the Company and the University such that all intellectual property, including all inventions and or discoveries, patentable or un-patentable, developed before July 28, 2008 by the University under the SRA is owned by OU. All intellectual property, including all inventions and/or discoveries, patentable or un-patentable, developed jointly by the Company and the University at any time is jointly owned by the Company and OU. Finally, all intellectual property developed by the Company after July 28, 2008, including all inventions and or discoveries, patentable or un-patentable, is owned by the Company. | |
OCAST_Grant
OCAST Grant | 12 Months Ended |
Dec. 31, 2014 | |
Oklahoma Center For Advancement Of Science and Technology Grant [Abstract] | |
OCAST Grant | Note 5 – OCAST Grant |
In July 2013, the Company was awarded a two year grant from OCAST. This is the second $300,000 grant received from OCAST. The first grant was completed in August 2012. This matching grant is for a total of $300,000 and commenced September 1, 2013. The Company earned $70,748 and $43,896 from the grant during the years ended December 31, 2014 and 2013, respectively. The funds are being used to support the development of the Company’s first Product Platform, which will be the basis for a family of products based on the Company’s CSpace® volumetric 3D display technology. | |
Consulting_Agreements
Consulting Agreements | 12 Months Ended |
Dec. 31, 2014 | |
Consulting Agreements [Abstract] | |
Management Agreement | Note 6 – Consulting Agreements |
Concordia Financial Group | |
The Company entered into a one-year Independent Consulting Agreement with Concordia Financial Group (“Concordia”) effective November 1, 2007, and month-to-month thereafter. Under the terms of the agreement Concordia will serve as liaison to Golden State Investors, Inc. and provide business strategy services by assisting the Company by reviewing and evaluating the Company's plans, personnel, board composition, technology, development of business models, building financial models for projections, developing materials to describe the Company, developing capital sources and assisting and advising the Company in its financial negotiations with capital sources. Concordia also advises with respect to effective registration of offerings of Company securities, the management team, the Company's development of near and long-term budgets, marketing strategies and plans, and assists in presentations related to the above services. Concordia is paid a monthly fee of $15,750. Concordia, at its option, may take up to 100% of this monthly fee in registered stock at 50% discount to market; and the Company, at its option, may pay up to 50% of Concordia's monthly invoice in registered stock, at 50% discount to market, provided that the payment of stock is made within ten (10) days of receipt of invoice and further provided that the stock trades above $.30 per share at any time during the last business day of the month. Market is defined as the five day average of closing prices immediately preceding the last business day of the calendar month in which the invoiced services were rendered. The monthly fee was reduced to $15,000 monthly effective June 1, 2013 under the revised terms of the agreement. Effective March 1, 2014 the agreement was revised again to reduce the monthly fee to $12,500 monthly. The Company incurred consulting fees of $155,000 and $183,750, respectively for services from Concordia during each of the periods ended December 31, 2014 and 2013, under the terms of the agreement. | |
Bayside Materials Technology | |
The Company entered into a Consulting Agreement with Bayside Material Technology (“Bayside”) effective November 1, 2013. Under the terms of the agreement Bayside will provide consulting services in the area of Federal Business Development. Bayside is paid an hourly fee of $176 for each hour of consulting time through the period ending November 11, 2014. The Company incurred consulting fees of $90,244 and -0- for the years ending December 31, 2014 and December 31, 2013 respectively. | |
Debentures_and_Notes_Payable
Debentures and Notes Payable | 12 Months Ended | |||||||
Dec. 31, 2014 | ||||||||
Debt Disclosure [Abstract] | ||||||||
Debentures and Notes Payable | Note 7 – Debentures and Notes Payable | |||||||
Debentures payable consist of the following: | ||||||||
December 31, | December 31, | |||||||
2014 | 2013 | |||||||
Senior Convertible Debentures: | ||||||||
10% Convertible debentures to Directors due June 2015 | $ | 30,000 | $ | 30,000 | ||||
10% Convertible debenture due June 2015 | 29,007 | 29,007 | ||||||
4.75% Convertible debenture due December 2014 | 65,095 | 69,805 | ||||||
5.0% Convertible notes due 2014 (net of $498 and $19,115 OID) | 74,502 | 123,590 | ||||||
10% Convertible bridge notes due August 2015 (net of $2,813 OID) | 147,187 | - | ||||||
15% Convertible bridge notes due 2014 (net of $23,500 OID) | - | 181,500 | ||||||
Settlement Agreement 3(a)(10) | - | 118,842 | ||||||
10% Convertible bridge note to Director due December 2014 | 60,000 | 60,000 | ||||||
Total Debentures Payable | $ | 405,791 | $ | 612,744 | ||||
10% Convertible Debentures to Directors due December 31, 2014 and subsequently extended to June 30, 2015 | ||||||||
On June 24, 2013, the Company issued to Victor Keen and Martin Keating, Directors of the Company, (“Directors”) 10% convertible debentures in a principal amount of $15,000 each, due June 26, 2014 and subsequently extended to June 30, 2015. The Directors may elect to convert all or any portion of the outstanding principal amount of the debentures at an exercise price of $0.01 per share. Provided that the debentures are paid in full on or before the maturity date, no interest shall accrue on the unpaid balance of the principal amount. In the event that the debentures are not paid in full on or before the maturity date, interest shall accrue on the unpaid outstanding balance of the principal amount of the debentures from June 26, 2013, until paid, at the fixed rate of ten percent (10%) per annum. | ||||||||
10% Convertible Debenture due Newton, O'Connor, Turner & Ketchum, due December 31, 2014 and subsequently extended to June 30, 2015 | ||||||||
On December 20, 2012, the Company issued to Newton, O'Connor, Turner & Ketchum (“NOTK”) a 10% convertible debenture in a principal amount of $29,007, initially due September 30, 2013 and extended to June 30, 2014 and subsequently extended to June 30, 2015. NOTK may elect to convert all or any portion of the outstanding principal amount of the debenture at an exercise price of $0.02534 per share. The Company was indebted to NOTK for legal services performed for the Company and reimbursement of expenses in rendition of those services for the period ended December 31, 2012. The debenture was issued in settlement of the indebtedness. | ||||||||
4.75% Convertible Debenture due December 31, 2014 | ||||||||
On November 3, 2006, the Company issued to Golden State a 4.75% convertible debenture in a principal amount of $100,000, due in December 31, 2014, (see Note 12) and warrants to buy 28,571 shares of the common stock at an exercise price of $381.50 per share. In connection with each conversion, Golden State is expected to simultaneously exercise a percentage of warrants equal to the percentage of the principal being converted. During 2013, Golden State converted $3,860 of the $100,000 debenture into 37,651,544 shares of common stock, exercised warrants to purchase 1,103 shares of common stock at $381.50 per share based on the formula in the convertible debenture. Additionally Golden State advanced $671,810 against future exercises of warrants of which $420,740 was applied to the exercise of warrants leaving $185,671 of unapplied advances at December 31, 2013. During 2014, Golden State converted $4,710 of the $100,000 debenture into 98,093,643 shares of common stock, exercised warrants to purchase 1,347 shares of common stock at $381.50 per share based on the formula in the convertible debenture. Additionally Golden State advanced $349,310 against future exercises of warrants of which $513,390 was applied to the exercise of warrants leaving $21,591 of unapplied advances at December 31, 2014. | ||||||||
The conversion price for the 4.75% $100,000 convertible debenture is the lesser of (i)$140 or (ii) 80% of the average of the five lowest volume weighted average prices during the twenty (20) trading days prior to the conversion. If Golden State elects to convert a portion of the debenture and, on the day that the election is made, the volume weighted average pre-split price is below $0.70, the Company shall have the right to prepay that portion of the debenture that Golden State elected to convert, plus any accrued and unpaid interest, at 135% of such amount. | ||||||||
5% Convertible Bridge Notes | ||||||||
On June 6, 2012 and August 1, 2012, the Company issued and sold convertible promissory notes (the “5% Notes") in aggregate principal amount of $415,000 to JMJ Financial (“JMJ”). The 5% Notes includes a $40,000 original issue discount (the “OID”) that will be prorated based on the advances actually paid to the Company. During 2012, JMJ advanced $150,000 on the 5% Notes and earned $14,000 OID. During 2013, JMJ advanced an additional $120,000 on the 5% Notes and earned $32,205 OID and accrued interest. During 2013, JMJ converted $203,700 of the 5% Notes into 31,854,924 shares of common stock at an average of $0.00639 per share based on the formula in the 5% Notes. During 2014, JMJ advanced an additional $75,000 on the 5% Notes and earned $5,975 OID and accrued interest. During 2014, JMJ converted $148,680 of the 5% Notes into 47,848,529 shares of common stock at an average of $0.003 per share based on the formula in the 5% Notes. In addition to the OID, the 5% Notes provides for a one-time interest charge of 5% to be applied to the principal sum advanced. Pursuant to the terms of 5% Notes, JMJ may, at its election, convert all or a part of the $275,000 note and the $140,000 note into shares of the Company's common stock at a conversion rate equal to the lesser of (i) $0.15 and $0.35, respectively or (ii) 70% of the lowest trade price during the twenty-five trading days prior to JMJ’s election to convert. If the Company repays the 5% Notes on or before ninety days from the date it was issued, the interest rate will be zero percent. If the Company does not repay the 5% Notes on or before ninety days from the date it was issued, a one-time interest charge of 5% shall be applied to the principal. The Company did not repay the 5% Notes within the ninety day period. The principal of the 5% Notes is due one year from the date of each of the principal amounts advanced. | ||||||||
The 5% Notes were subject to a Mandatory Registration Agreement (the “Registration Agreement”) whereby no later than August 31, 2012, the Company agreed to file, at its own expense, an amendment (the “Amendment”) to the S-1 Registration Statement (the “Registration Statement”) the Company filed with the SEC on July 3, 2012, to include in such Amendment 4,750,000 shares of common stock issuable under the 5% Notes. The Company agreed, thereafter, to use its best efforts to cause such Registration Statement to become effective as soon as possible after such filing but in no event later than one hundred and twenty (120) days from the date of the Registration Agreement. Since the Company failed to get the Registration Statement declared effective within the 120 days of the date of the Registration Agreement, a penalty/liquidated damages of $25,000 was added to the balance of the 5% Notes. | ||||||||
10% Convertible Debenture due August 2015 | ||||||||
On August 15, 2014, the Company issued and sold to an accredited investor a Convertible Debenture (the “10% Debenture”) in the principal amount of $150,000. The 10% Debenture included a 3% original issue discount. Accordingly, the Company received $145,500 gross proceeds, from which the Company paid legal and fees of $5,000. The 10% Debenture has a maturity date of August 15, 2015 and carries a 10% interest rate. Subject to a 4.99% beneficial ownership limitation, the holder of the 10% Debenture may, at any time, elect to convert all or any portion of the outstanding principal amount of the 10% Debenture into shares of Common Stock at a conversion price equal Sixty Five Percent (65%) of the lowest traded VWAP, determined on the then current trading market for the Company’s common stock, for 15 trading days prior to conversion. | ||||||||
10% Convertible Bridge Notes | ||||||||
On August 24, 2012, August 28, 2012 and September 11, 2012, the Company issued and sold to three accredited investors Convertible Bridge Notes (the “Bridge Notes”) in the aggregate principal amount of $438,000. The note sold on August 24, 2012, in principal amount of $300,000, was purchased by GCA Strategic Investment Fund Limited, a Bermuda corporation ("GCASIF"). The note sold August 28, 2012, in principal amount of $78,000, was purchased by George Widener. The note sold on September 11, 2012, in principal amount of $60,000, was purchased by Victor Keen, a director of the Company. The sale of the Bridge Notes in aggregate principal of $438,000 included a $73,000 original issue discount. Accordingly, the Company received $365,000 gross proceeds from which the Company paid legal fees of $25,000 and placement agent fees of $27,675. The Bridge Notes mature in 90 days from their date of issuance and, other than the original issue discount, the Bridge Notes do not carry interest. However, in the event the Bridge Notes are not paid on maturity, all past due amounts will accrue interest at 15% per annum. Upon maturity of the Bridge Notes, the holders of the Bridge Notes may elect to convert all or any portion of the outstanding principal amount of the Bridge Notes into (i) securities sold pursuant to an effective registration statement at the applicable offering price; or (ii) shares of common stock at a conversion price equal to the lesser of 100% of the Volume Weighted Average Price (VWAP), as reported for the 5 trading days prior to (a) the date of issuance of the Bridge Notes, (b) the maturity date of the Bridge Notes, or (c) the first closing date of the securities sold pursuant an effective registration statement. The GCA Bridge Note matured on or about November 22, 2012, on which date all past due amounts of the GCA Bridge Note began accruing interest at 15% per annum. Furthermore, on November 22, 2012, because the shares of the Company’s common stock into which the GCA Bridge Note is convertible were not registered under an effective registration statement (the “Registration Statement”), GCASIF was entitled to liquidated damages equal to 2% of the outstanding principal for each 30 day period after the November 22, 2012 the Registration Statement is not declared effective (the “Liquidated Damages”). | ||||||||
On December 21, 2012, the Company entered into an amendment agreement (the “GCASIF Amendment”) with GCASIF, the holder of that certain Convertible Bridge Note (the “GCA Bridge Note”) in the principal amount of $300,000. Pursuant to the GCASIF Amendment, GCASIF agreed to extend the maturity of the GCA Bridge Note from November 22, 2012 to March 21, 2013 and the Company agreed to (i) increase the principal amount of the GCA Bridge Note from $300,000 to $325,000; (ii) amend the conversion price of the GCA Bridge Note to the lesser of $0.04, or 100% of the VWAP, as reported by Bloomberg, L.P., for the 5 trading days prior to the effective date of the Registration Statement; and (iii) grant additional registration rights to GCASIF from 5,172,414 shares to 8,000,000 shares of the Company’s common stock into which the GCA Bridge Note may be convertible. Furthermore, GCASIF agreed to waive any and all defaults, default interest and the Liquidated Damages due to GCASIF. In connection with the GCASIF Amendment, the Company agreed to pay GCASIF a fee of $20,000. GCASIF agreed to waive any defaults resulting from the non-payment of the GCA Bridge Note, so long as, GCASIF is paid in full by April 15, 2013 or GCASIF elects to convert the GCA Bridge Note into shares of the Company’s common stock on or before April 15, 2013. In April 2013, the GCA Bridge Note was assigned to a successor in interest and the Company executed an amendment to the GCA Bridge Note in order to extend the maturity until July 22, 2014 and reduce the conversion price to the greater of (x) the par value of the Common Stock, or (y) 60% of the lowest closing bid price, as reported by Bloomberg, L.P., for the 10 trading days prior to the date the conversion of all or part of its principal and interest are requested. During 2013, GCASIF converted $204,480 of the note into 48,811,800 shares of common stock at an average of $0.0042 per share based on the formula in the note. The $120,520 remaining balance on the note was paid in cash in December 2013. | ||||||||
On January 26, 2013, the Company entered into an amendment agreement (the “Widener Amendment”) with George Widener, the holder of that certain Convertible Bridge Note (the “Widener Bridge Note”) in the principal amount of $78,000 issued by the Company on August 30, 2012. | ||||||||
The Widener Bridge Note matured on or about November 26, 2012, on which date all past due amounts of the Widener Bridge Note began accruing interest at 15% per annum. Pursuant to the Widener Amendment, Mr. Widener agreed to extend the maturity date of the Widener Bridge Note from November 26, 2012 to April 30, 2013 and to waive any and all defaults, default interest and Liquidated Damages then due to Mr. Widener. On April 30, 2013, Mr. Widener converted the entire $78,000 balance of the Widener Bridge Note into 2,025,974 shares of common stock. | ||||||||
On January 26, 2013, the Company entered into an amendment agreement (the “Keen Amendment”) with Victor F. Keen, the holder of that certain Convertible Bridge Note (the “Keen Bridge Note”) in the principal amount of $60,000 issued by the Company on September 10, 2012. | ||||||||
The Keen Bridge Note matured on or about December 10, 2012, on which date all past due amounts of the Keen Bridge Note began accruing interest at 15% per annum. Pursuant to the Keen Amendment, Mr. Keen agreed to extend the maturity date of the Keen Bridge Note from December 10, 2012 to April 30, 2013 and to waive any and all defaults, default interest and Liquidated Damages then due to Mr. Keen. | ||||||||
On July 30, 2013 (the “Amendment Date”), the Company entered into a second amendment agreement (the “Second Keen Amendment”) with Mr. Keen to amend the Keen Bridge note. | ||||||||
Pursuant to the Second Keen Amendment, Mr. Keen agreed to extend the maturity of the Note from May 15, 2013 to August 31, 2013 (the “New Maturity Date”) and to waive, if any, existing or prior defaults under the Keen Bridge Note or the Keen SPA and the Company agreed to (i) amend the conversion provision to allow for conversions based on a conversion price calculated on the Amendment Date or the New Maturity Date; and (ii) to include an interest rate equal to 10% per annum, payable on the New Maturity Date, as amended, which accrual shall commence on December 10, 2012. | ||||||||
On September 30, 2013 (the “Amendment Date”), the Company entered into a third amendment agreement (the “Third Keen Amendment”) with Victor Keen, a Director on the Board of Directors of the Company, to amend the Keen Bridge note. Pursuant to the Third Keen Amendment, Mr. Keen agreed to extend the maturity of the Note from August 31, 2013 to December 31, 2013 (the “New Maturity Date”) and to waive, if any, existing or prior defaults under the Keen Bridge Note or the Keen SPA. | ||||||||
On January 27, 2014, the Company entered into a fourth amendment agreement (the “Fourth Keen Amendment”) with Mr. Keen. Pursuant to the Fourth Keen Amendment, Mr. Keen agreed to extend the maturity of the Note from December 31, 2013 to December 31, 2014 and to waive, if any, existing or prior defaults under the Keen Bridge Note or the Keen SPA. | ||||||||
(see Note 12) | ||||||||
15% Convertible Bridge Notes due 2014 | ||||||||
On October 1, 2013 (the “Date of Issuance”), 3DIcon Corporation issued and sold to an accredited investor a Senior Convertible Note (the “Senior Note”) in the principal amount of $205,000 and a warrant to purchase 300,000 shares of the Company’s common stock at an exercise price equal to 110% of the closing bid price on September 30, 2013 (the “October 2013 Warrant”). The Senior Note included a $30,750 original issue discount. Accordingly, the Company received $174,250 gross proceeds from which the Company paid legal and documentation fees of $22,500 and placement agent fees of $15,682. | ||||||||
The Senior Note matured on July 1, 2014 and does not carry interest. However, in the event the Senior Note is not paid on maturity, all past due amounts will accrue interest at 15% per annum. At any time subsequent to six months following the Date of Issuance, the Senior Note holder may elect to convert all or any portion of the outstanding principal amount of the Senior Note into shares of Common Stock at a conversion price equal to the lesser of 100% of the Volume Weighted Average Price (VWAP), as reported for the 5 trading days prior to the Date of Issuance or 80% of the average VWAP during the 5 days prior to the date the holder delivers a conversion notice to the Company. During 2014, the holder of the $205,000 note converted $180,000 of the note into 83,705,721 common shares at an average price of $0.002 per share under the terms of the debenture agreement. The remaining $25,000 balance of the note was paid in cash to retire the note. | ||||||||
The estimated fair value of the warrants for common stock issued of $2,130 was determined using the Black-Scholes option pricing model. The expected dividend yield of zero is based on the average annual dividend yield as of the issue date. Expected volatility of 173.64% is based on the historical volatility of our stock. The risk-free interest rate of 1.39% is based on the U.S. Treasury Constant Maturity rate for five years as of the issue date. The expected life of five years of the warrant is based on historical exercise behavior and expected future experience. | ||||||||
The October 2013 Warrant is exercisable at any time on or after March 31, 2014 and on or prior to the close of business on March 31, 2019. At the election of the October 2013 Warrant holder, the October 2013 Warrant may be exercised using a cashless exercise method. | ||||||||
The Senior Note and October 2013 Warrant were offered and sold to an accredited investor on October 1, 2013 in a private placement transaction made in reliance upon exemptions from registration pursuant to Section 4(2) under the Securities Act of 1933. | ||||||||
Effective August 15, 2014, the Company entered into a Securities Settlement Agreement (the “SSA”) with an accredited investor (the “Investor”) to whom the $205,000 Senior Convertible Note was assigned. Pursuant to the SSA, the Investor agreed to extend the maturity of the $205,000 principal owed (the “Debt”) under the Senior Note until August 15, 2015 and the Company agreed, among other things, to (i) pay 10% interest on the Debt; (ii) pay 125% of principal in the event the Company elects to prepay any portion of the Debt; (iii) allow the Investor to convert the Debt, in whole or in part, into shares of the Company’s common stock at a conversion price equal to 58% percent of the lowest traded VWAP, determined on the then current trading market for the Company’s common stock, for the 15 trading days prior to conversion. | ||||||||
Settlement Agreement | ||||||||
On July 26, 2013, the Circuit Court in the 12th Judicial Circuit in and for Sarasota County, Florida (the “Court”), entered an Order Granting Approval of Settlement Agreement (the “Order”) approving, among other things, the fairness of the terms and conditions of an exchange pursuant to Section 3(a)(10) of the Securities Act of 1933, as amended, in accordance with a Settlement Agreement (the “Settlement Agreement”) between the Company and IBC Funds, LLC, a Nevada limited liability company (“IBC”), in the matter entitled IBC Funds, LLC v. 3DIcon Corporation, Case No. 2013 CA 5705 NC (the “Action”). IBC commenced the Action against the Company on July 19, 2013 to recover an aggregate of $197,631 of past-due accounts payable of the Company, which IBC had purchased from certain vendors of the Company pursuant to the terms of separate claim purchase agreements between IBC and each of such vendors (the “Assigned Accounts”), plus fees and costs (the “Claim”). The Assigned Accounts relate to certain research, technical, development, accounting and legal services. The Order provides for the full and final settlement of the Claim and the Action. The Settlement Agreement became effective and binding upon the Company and IBC upon execution of the Order by the Court on July 26, 2013. | ||||||||
Pursuant to the terms of the Settlement Agreement approved by the Order, on July 26, 2013, the Company issued 650,000 shares of Common Stock as a settlement fee and agreed to issue, in one or more tranches as necessary, that number of shares equal to $197,631 upon conversion to Common Stock at a conversion rate equal to 65% of the lowest closing bid price of the Common Stock during the ten trading days prior to the date the conversion is requested by IBC minus $0.002. During 2013, IBC converted $78,789 of the note into 53,720,000 shares of common stock at an average of $0.002 per share based on the formula in the note. | ||||||||
On January 22, 2014 the Company entered into a Mutual Release (the “Release”) with IBC Funds, LLC pursuant to which each party would release the other party from any and all obligations pursuant to that certain court-approved Settlement Agreement dated as of July 26, 2013, as described in the Company’s Current Report on Form 8-K filed on July 31, 2013. | ||||||||
In consideration for the Release, IBC will accept and the Company will remit to IBC: (i) a cash payment of $190,000, (ii) an issuance of 9,000,000 shares of the Company’s common stock, pursuant to the terms of the Settlement Agreement under the December 18, 2013 Conversion Notice, and (iii) an issuance of 6,810,811 shares of the Company’s common stock, pursuant to the terms of the Settlement Agreement under the January 17, 2014 Conversion Notice (together, the “Consideration”). Pursuant to the Release, IBC has agreed that the Consideration shall be accepted as satisfaction in full of the payments due pursuant to the Settlement Agreement. | ||||||||
On January 23, 2014, the Company and IBC filed a Stipulation of Dismissal with Prejudice with the Circuit Court in the 12th Judicial Circuit in and for Sarasota County, Florida. | ||||||||
Common_Stock_and_PaidIn_Capita
Common Stock and Paid-In Capital | 12 Months Ended | |||||||
Dec. 31, 2014 | ||||||||
Common Stock, Including Additional Paid In Capital, Net Of Discount [Abstract] | ||||||||
Common Stock and Paid-In Capital | Note 8 – Common Stock and Paid-In Capital | |||||||
Registration Statement on Form S-1 | ||||||||
Pursuant to a Registration Statement on Form S-1 and the prospectus therein, filed on July 3, 2012, and amendment thereto, the Registration Statement was declared effective on February 13, 2013. | ||||||||
Downgraded from the OTCQB to the OTC Pink | ||||||||
On September 2, 2014, the Company received notification from OTC Markets that because the Company’s common stock, which trades under the symbol TDCP, has not had a minimum closing bid price of $.01 during the last thirty days, it has been downgraded from the OTCQB to the OTC Pink, effective September 3, 2014. On March 26, 2014, OTC Markets had announced a series of rule changes to take place between May 1, 2014 and April 1, 2015. These rules set forth new qualifications and fees for quotation of securities on the various tiers of OTC Markets. One of such changes requires that a company’s stock have a minimum closing bid price of $.01 for at least one day in any consecutive thirty day period to continue being quoted on the OTCQB. | ||||||||
The Company has the option of filing an application for reinstatement to have its common stock quoted on the OTCQB. The Company’s common stock could be reinstated to the OTCQB commencing at such time as it has had a minimum closing bid price of $.01 for any consecutive 30 day period. The downgrading of the Company’s common stock from the OTCQB to the OCT Pink will have no effect on the common stock’s ability to trade or its DWAC (method of electronic transfer of shares) eligibility. | ||||||||
Warrants issued | ||||||||
As of December 31, 2014, NOTK has warrants outstanding to purchase 125,098 shares of common stock at a price of $3.15 per share that expire on September 30, 2016 and, warrants to purchase 96,024 shares of common stock at a price of $3.15 per share that expire on June 1, 2015. Golden State has warrants outstanding to purchase 18,595 shares of common stock at a price of $381.50 per share which expired December 31, 2014 (See Note 12). Global Capital has warrants outstanding to purchase 300,000 shares of common stock at a price of $0.0032 per shares which expire on March 31, 2019. Additionally from the preferred stock issuance, there are 9,750,000 warrants outstanding to purchase common shares at $0.0055 per share which expire December 31, 2017 and 9,500,000 warrants outstanding that were issued to Victor Keen, the CEO and Director of the Company, which expire on January 17, 2018. | ||||||||
Common stock and options issued for services and liabilities | ||||||||
During the years ending December 31, 2014 and 2013, shares of common stock totaling 28,205,571 and 25,892,479, respectively were issued for consulting services for which the Company recognized $108,500 and $295,350 of expense, respectively. Additionally, during the years ending December 31, 2014 and 2013, shares totaling 13,131,828 and 1,098,751, respectively were issued to consultants for previous services provided to the Company for which the accounts payable liability was reduced by $6,267 and $31,500, respectively. | ||||||||
Employment Agreement - On March 13, 2012, the Company entered into a one (1) year Agreement for At-Will Employment with Assignment of Inventions (“Employment Agreement”) with Mark Willner, pursuant to which Mr. Willner began serving as the Company’s Chief Executive Officer, effective immediately. Under the terms of the Employment Agreement, Mr. Willner was entitled to an annual base salary of $180,000, and, at the discretion of the Company’s Board of Directors, performance-based bonuses and/or salary increases. Pursuant to the Employment Agreement, the Company granted Mr. Willner five-year stock options to purchase 57,143 shares at a price equal to the average price of the five day period prior to March 19, 2012 which was $0.35 (the “Strike Price”). Furthermore, since Mr. Willner remained employed by the Company at the end of each quarter ending June 30, 2012, September 30, 2012 and December 31, 2012, he received additional stock options to purchase 28,571.5 shares at the Strike Price. In addition, since the Company achieved certain quarterly business objectives, Mr. Willner received, at the end of each such quarterly period, a further grant of stock options to purchase 28,571.5 shares at the Strike Price. The estimated fair value of each of the 57,143 block of options, valued at $18,840, was determined using the Black-Scholes option pricing model and was charged to operations in March 2012, June 2012, September 2012 and December 2012. The expected dividend yield of $-0- is based on the average annual dividend yield as of the grant date. Expected volatility of 163% is based on the historical volatility of the stock since July 25, 2007, the day the Company began trading on the Over-The-Counter Bulletin Board. The risk-free interest rate of 1.87% is based on the U.S. Treasury Constant Maturity rates as of the grant date. The expected life of the option of five years is based on historical exercise behavior and expected future experience. On November 1, 2013, Mark Willner resigned as Chief Executive Officer. | ||||||||
Employment Agreement - On March 16, 2012, the Company entered into a one (1) year Agreement for At-Will Employment with Assignment of Inventions (“Employment Agreement”) with George Melnik, pursuant to which Dr. Melnik began serving as the Company’s Senior Technical Advisor, effective immediately. Under the terms of the Employment Agreement, Dr. Melnik is entitled to an annual base salary of $144,000, and, at the discretion of the Company’s Board of Directors, performance-based bonuses and/or salary increases. Pursuant to the Employment Agreement, the Company granted Dr. Melnik five-year stock options to purchase 28,571 shares at a price equal to the average price of the five day period prior to March 16, 2012 which was $0.35 (the “Strike Price”). Furthermore, since Dr. Melnik remained employed by the Company at the end of each quarter ending June 30, 2012, September 30, 2012 and December 31, 2012, he received additional stock options to purchase 28,571 shares at the Strike Price. In addition, since the Company achieved certain quarterly business objectives, Dr. Melnik received, at the end of each such quarterly period, a further grant of stock options to purchase 28,571 shares at the Strike Price. The estimated fair value of each of the 28,571 block of options, valued at $9,420, was determined using the Black-Scholes option pricing model and was charged to operations in March 2012, June 2012, September 2012 and December 2012. The expected dividend yield of $-0- is based on the average annual dividend yield as of the grant date. Expected volatility of 163% is based on the historical volatility of the stock since July 25, 2007, the day the Company began trading on the Over-The-Counter Bulletin Board. The risk-free interest rate of 1.87% is based on the U.S. Treasury Constant Maturity rates as of the grant date. The expected life of the option of five years is based on historical exercise behavior and expected future experience. | ||||||||
The Employment Agreement may be terminated with or without reason by either the Company or Dr. Melnik and at any time, upon sixty (60) days written notice. The terms of the Employment Agreement will remain effective for one (1) year and will automatically renew, subject to the same termination rights. Upon termination, the Company will pay any base pay, bonus and benefits that have been earned and are due as of the date of the termination. | ||||||||
Employment Agreement - On January 28, 2013, the Board of Directors of the Company appointed Ronald Robinson to serve as the Company’s Chief Financial Officer. Accordingly, the Company decided not to renew its agreement with Christopher T. Dunstan pursuant to which Mr. Dunstan served as the Company’s Interim Chief Financial Officer. The Company’s appointment of Mr. Robinson and decision not to renew its agreement with Mr. Dunstan was not as a result of any disagreement between the Company and Mr. Dunstan. | ||||||||
On April 11, 2013, the Company completed the sale of two options, each to purchase 10,000,000 shares of the Company’s common stock (the “Option Agreements”) to two accredited investors. One of the accredited investors was Victor Keen, a director on the Board of Directors of the Company. Each of the Option Agreements provide for the option to purchase up to 10,000,000 shares of restricted common stock at a purchase price of $0.01 per share. The holders of the Option Agreements may exercise the option to purchase common stock on a cashless basis for a period of five years. Furthermore, the holders of the Option Agreements were granted “piggyback” registration rights for the inclusion, on a subsequent registration statement, the shares of common stock underlying the Option Agreements. The gross proceeds to the Company for the sale of both Option Agreements were $100,000. | ||||||||
Private Placement | ||||||||
On December 9, 2013 and December 11, 2013 the Company closed on $195,000 in a private placement (the “Private Placement”) contemplated by a Securities Purchase Agreement (the “Securities Purchase Agreement”), dated December 9, 2013, pursuant to which the Company sold 195,000 Units (as defined below) to accredited investors (each, an “Investor” and collectively, the “Investors”), one of whom was Victor Keen, the Company’s Chief Executive Officer and a member of the board of directors of the Company. Accordingly, at the closings, the Company issued (i) 195,000 shares of its newly designated Series A Convertible Preferred Stock (the “Series A Preferred”), and (ii) warrants (“Warrants”) to purchase an aggregate of 9,750,000 shares of Common Stock for gross proceed of $195,000. | ||||||||
On January 23, 2014, the Company sold to Victor Keen, the Company’s Chief Executive Officer and a member of the Company’s Board of Directors, 190,000 Units for a purchase price of $190,000, as part of the Private Placement (as defined therein) disclosed in the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on December 13, 2013. Pursuant to such Private Placement, the Company has received aggregate proceeds equal to $385,000. Such Private Placement is now closed. | ||||||||
Under the terms of the Securities Purchase Agreement, the Company sold units (“Units”) consisting of: (i) one share of Series A Convertible Preferred Stock and (ii) Warrants to purchase fifty (50) shares of Common Stock. The purchase price of each Unit was $1.00. The total purchase price of the securities sold in the Private Placement was $195,000. The offer and sale of the foregoing securities under the Securities Purchase Agreement was not a “public offering” as referred to in Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), and was intended meet the requirements to qualify for exemption under Rule 506(b) of Regulation D promulgated under the Securities Act. | ||||||||
The terms of the Series A Convertible Preferred Stock and Warrants are as follows: | ||||||||
Series A Convertible Preferred Stock | ||||||||
A total of 195,000 shares of Series A Convertible Preferred Stock (the “Series A Preferred Stock”) have been authorized for issuance under the Certificate of Designation of Preferences, Rights and Limitation of Series A Convertible Preferred Stock of 3DIcon Corporation (the “Certificate of Designation”), which Certificate of Designation was filed with the Secretary of State of the State of Oklahoma on December 11, 2013. The shares of Series A Preferred Stock have a par value of $0.0002 per share (the “Stated Value”), and shall receive a dividend of 6% of their Stated Value per annum. Under the Certificate of Designation, the holders of the Series A Preferred Stock have the following rights, preferences and privileges: | ||||||||
The Series A Preferred Stock may, at the option of the Investor, be converted at any time after the first anniversary of the issuance of the Series A Preferred Stock or from time to time thereafter into 50,000,000 shares of Common Stock that Such Investor is entitled to in proportion to the 500,000 shares of Series A Preferred so designated in the Certificate of Designation. | ||||||||
The Series A Preferred Stock will automatically be converted into Common Stock anytime the 5 day average VWAP of the Company’s Common Stock prior to such conversion is equal to $0.05 or more. Such mandatory conversion would be converted by the same method described above for discretionary conversions. | ||||||||
Except as otherwise required by law, the holders of shares of Series A Preferred Stock shall not have voting rights or powers. | ||||||||
In the event of any (i) liquidation, dissolution or winding up of the Company, whether voluntary or involuntary, or ii) sale, merger, consolidation, reorganization or other transaction that results in a change of control of the Company, each holder of a share of Series A Preferred shall be entitled to receive, subject to prior preferences and other rights of any class or series of stock of the Company senior to the Series A Preferred, but prior and in preference to any distribution of any of the assets or surplus funds of the Company to holders of Common Stock, or any other class or series of stock of the Company junior to the Series A Preferred, an amount equal to the Stated Value plus accrued and unpaid dividends (as adjusted for any stock dividends, combinations or splits with respect to such shares) (the “Preference Amount”). After such payment has been made to the holders of Series A Preferred of the full Preference Amount to which such holders shall be entitled, the remaining net assets of the Company available for distribution, if any, shall be distributed pro rata among the holders of Common Stock. In the event the funds or assets legally available for distribution to the holders of Series A Preferred are insufficient to pay the Preference Amount, then all funds or assets available for distribution to the holders of capital stock shall be paid to the holders of Series A Preferred pro rata based on the full Preference Amount to which they are entitled. | ||||||||
The Company may not declare, pay or set aside any dividends on shares of any class or series of capital stock of the Company (other than dividends on shares of Common Stock payable in shares of Common Stock) unless the holders of the Series A Preferred Stock shall first receive, or simultaneously receive, a dividend on each outstanding share of Series A Preferred in an amount equal to the dividend per share that such holders would have received had they converted their shares of Series A Preferred into shares of Common Stock immediately prior to the record date for the declaration of the Common Stock dividend in an amount equal to the average VWAP during the 5 trading days prior to the date such dividend is due. | ||||||||
Warrants | ||||||||
Each Unit under the Securities Purchase Agreement consists of Warrants entitling the Investor to purchase fifty (50) shares of Common Stock for each share of Series A Preferred purchased by such Investor in the Private Placement, at an initial exercise price per share of $0.0055. The exercise price and number of shares of Common Stock issuable under the Warrants are subject to adjustments for stock dividends, splits, combinations and similar events. On or after the first anniversary of the issuance of the Warrants and prior to close of business on fourth anniversary of the issuance of the Warrants and may be exercised at any time upon the election of the holder, provided however, that an Investor may at any given time convert only up to that number of shares of Common Stock so that, upon conversion, the aggregate beneficial ownership of the Company’s Common Stock (calculated pursuant to Rule 13d-3 of the Securities Exchange Act of 1934, as amended) of such Investor and all persons affiliated with such Investor, is not more than 4.99% of the Company’s Common Stock then outstanding (subject to adjustment up to 9.99% at the Investor’s discretion upon 61 days’ prior notice). | ||||||||
The $27,000 estimated fair value of warrants for common stock issued was determined using the Black-Scholes option pricing model. The expected dividend yield of $0 is based on the average annual dividend yield at the date issued. Expected volatility of 178% is based on the historical volatility of the stock. The risk-free interest rate of 1.38% is based on the U.S. Treasury Constant Maturity rates as of the issue date. The expected life of the warrants of five years is based on historical exercise behavior and expected future experience. | ||||||||
Transaction Documents Series A Convertible Preferred Stock | ||||||||
The Securities Purchase Agreement, the Warrants and Certificate of Designation contain ordinary and customary provisions for agreements of this nature, such as representations, warranties, covenants, and indemnification obligations, as applicable. The foregoing descriptions of the Securities Purchase Agreement and the Warrants do not purport to describe all of the terms and provisions thereof and are qualified in their entirety by reference. The Securities Purchase Agreement and the form of Warrant are filed as Exhibits 4.1 and 10.1, respectively, to the Current Report on Form 8-K filed on December 13, 2013 and are incorporated herein by reference. | ||||||||
The following summary reflects warrant and option activity for the year ending December 31, 2014: | ||||||||
Attached | Golden State | |||||||
Warrants | Warrants | Options | ||||||
Outstanding December 31, 2013 | 10,271,122 | 19,942 | 23,030,274 | |||||
Granted/purchased | 9,500,000 | - | - | |||||
Exercised | - | -1,347 | - | |||||
Cancelled | - | - | - | |||||
Outstanding December 31, 2014 | 19,771,122 | 18,595 | 23,030,274 | |||||
Stock options are valued at the date of award, which does not precede the approval date, and compensation cost is recognized in the period the options are granted. Stock options generally become exercisable on the date of grant and expire based on the terms of each grant. | ||||||||
The estimated fair value of options for common stock granted was determined using the Black-Scholes option pricing model. The expected dividend yield is based on the average annual dividend yield as of the grant date. Expected volatility is based on the historical volatility of our stock. The risk-free interest rate is based on the U.S. Treasury Constant Maturity rates as of the grant date. The expected life of the option is based on historical exercise behavior and expected future experience. | ||||||||
Incentive_Stock_Plan
Incentive Stock Plan | 12 Months Ended |
Dec. 31, 2014 | |
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |
Incentive Stock Plan | Note 9 – Incentive Stock Plan |
In June 2013, the Company established the 3DIcon Corporation 2013 Equity Incentive Plan (the "2013 EIP"). The total number of shares of stock which may be purchased or granted directly by options, stock awards or restricted stock purchase offers, or purchased indirectly through exercise of options granted under the 2013 EIP shall not exceed twenty million (20,000,000) shares. The shares are included in a registration statement filed June 10, 2013. Shares totaling 20,000,000 were issued from the 2013 EIP during 2013 for services rendered. As of December 31, 2014 there are -0- shares available for issuance under the 2013 EIP. | |
In March 2014, the Company established the 3DIcon Corporation 2014 Equity Incentive Plan (the “2014 EIP”). The total number of shares of stock which may be purchased or granted directly by options, stock awards or restricted stock purchase offers, or purchased indirectly through exercise of options granted under the 2014 EIP shall not exceed fifty million (50,000,000) shares. The shares are included in a registration statement filed March 2014. Shares totaling 42,456,419 were issued from the 2014 EIP during 2014 for services rendered. As of December 31, 2014, there were 7,543,581 shares available for issuance under the 2014 EIP. (see Note 12) | |
Office_Lease
Office Lease | 12 Months Ended |
Dec. 31, 2014 | |
Leases [Abstract] | |
Office Lease | Note 10 – Office Lease |
The Company signed an Office Lease Agreement (the “Lease Agreement”) on April 24, 2008. The Lease Agreement commenced on June 1, 2008 and expired June 1, 2011. On March 8, 2011 the Lease Agreement was amended (amendment 1) to extend the expiration date to May 31, 2012. On July 24, 2012 the Lease Agreement was amended (amendment 2) to extend the expiration date to July 31, 2015. The minimum future lease payment to be paid under the remaining 2015 term is $13,000 under the three-year non-cancellable amended operating lease for office space. | |
Related_Party_Transaction
Related Party Transaction | 12 Months Ended |
Dec. 31, 2014 | |
Related Party Transactions [Abstract] | |
Related Party Transaction | Note 11 – Related Party Transaction |
3DIcon has engaged the law firm of Newton, O’Connor, Turner & Ketchum as its outside corporate counsel since 2005. John O’Connor, a director of 3DIcon, is the Chairman of Newton, O’Connor, Turner & Ketchum. During the years ending December 31, 2014 and December 31, 2013, the Company incurred legal fees to Newton, O’Connor, Turner & Ketchum in the amount of $3,360 and $23,137, respectively. | |
Subsequent_Events
Subsequent Events | 12 Months Ended |
Dec. 31, 2014 | |
Subsequent Events [Abstract] | |
Subsequent Events | Note 12 – Subsequent Events |
Common stock issued for services and liabilities | |
Subsequent to December 31, 2014, Golden State converted $400 of the 4.75% convertible debenture into 18,727,884 shares of common stock at $0.00002 per share and exercised 114 warrants at $381.50 per share for $43,545 and advanced $10,900 for future exercise of warrants under the terms of the securities purchase agreements. Additionally, Golden Gate extended the debenture due date to December 31, 2016. | |
Subsequent to December 31, 2014, JMJ converted $17,500 of the convertible promissory note into 10,000,000 shares of common stock at $0.002 under the terms of the securities purchase agreements. | |
Subsequent to December 31, 2014, the holder of the 10% Convertible Promissory Note converted $25,000 of the convertible promissory note into 14,245,014 shares of common stock at $0.002 under the terms of the securities purchase agreements. | |
Subsequent to December 31, 2014, shares of common stock totaling 15,000,000 were issued for legal services for which the Company recognized $22,500 of expense. | |
Subsequent to December 31, 2014, shares of common stock totaling 15,017,162 were issued for 2014 consulting services for which the Company reduced accounts payable by $25,000. | |
Keen Bridge Note | |
On March 16, 2015 (the “Amendment Date”), the Company entered into a fifth amendment agreement (the “Fifth Keen Amendment”) with Victor Keen, a Director on the Board of Directors of the Company, to amend the Keen Bridge note. Pursuant to the Fifth Keen Amendment, Mr. Keen agreed to extend the maturity of the Note from December 31, 2014 to June 30, 2015 (the “New Maturity Date”) and to waive, if any, existing or prior defaults under the Keen Bridge Note or the Keen SPA. | |
Incentive Stock Plan | |
Shares totaling 6,793,478 were issued from the 2014 EIP during 2015 for prior services rendered for which the Company reduced accounts payable by $12,500. There are 750,103 shares available for issuance under the 2014 EIP. | |
In March 2015, the Company established the 3DIcon Corporation 2015 Equity Incentive Plan (the “2014 EIP”). The total number of shares of stock which may be purchased or granted directly by options, stock awards or restricted stock purchase offers, or purchased indirectly through exercise of options granted under the 2015 EIP shall not exceed eighty-five million (85,000,000) shares. The shares are included in a registration statement filed March, 2015. Shares totaling 23,223,684 were issued from the 2015 EIP during 2015 for $35,000 of legal and consulting services rendered. There are 61,776,316 shares available for issuance under the 2015 EIP. | |
JMJ March 2015 5% Note | |
In March 2015, the Company issued and sold a convertible note (the “March 2015 5% Note") in aggregate Principal Sum of $250,000 to JMJ Financial (“JMJ”). The 5% Note includes a $25,000 original issue discount (the “OID”) that will be prorated based on the advances actually paid (the “Principal Sum”) to the Company. During 2015, JMJ advanced $30,000 on the 5% Note and earned $3,000 OID. In addition to the OID, the March 2015 5% Note provides for a one-time interest charge of 5% to be applied to the Principal Sum. If the Company repays the 5% Note on or before ninety days from the date of the principal amount advanced, the interest rate will be zero percent. If the Company does not repay the March 2015 5% Note on or before ninety days from the date of the advance, a one-time interest charge of 5% shall be applied to the Principal Sum. Pursuant to the terms of March 2015 5% Note, JMJ may, at its election, convert all or a part of the $250,000 note into shares of the Company's common stock at a conversion rate 70% of the lowest trade price during the twenty-five trading days prior to JMJ’s election to convert. The principal of the March 2015 5% Note is due two years from the date of each of the principal amounts advanced. | |
Typenex Co-Investment, LLC | |
In March 2015, the Company issued and sold a convertible note (the “5% Promissory Note") in aggregate Principal Sum of $87,500 to Typenex Co-Investment, LLC, (“Typenex”). The 5% Promissory Note includes a $7,500 original issue discount (the “OID”) that will be prorated based on the advances actually paid to the Company. Accordingly during 2015, the Company received $80,000 gross proceeds from which the Company paid legal and documentation fees of $20,000 and placement agent fees of $6,750. In addition to the OID, the 5% Promissory Note provides for a one-time interest charge of 5% to be applied to the principal of the 5% Promissory Note. If the Company repays the 5% Promissory Note on or before ninety days from the date of the principal amount advanced, the interest rate will be zero percent. If the Company does not repay the 5% Promissory Note on or before ninety days from the date of the advance, a one-time interest charge of 5% shall be applied to the Principal Sum. Pursuant to the terms of 5% Promissory Note, Typenex may, at its election, convert all or a part of the $87,500 principal and interest thereon of the 5% Promissory Note into shares of the Company's common stock at a conversion rate 70% of the lowest trade price during the twenty-five trading days prior to the election to convert. The principal of the 5% Promissory Note is due one year from the March 2015 effective date. | |
Summary_of_Significant_Account1
Summary of Significant Accounting Policies (Policies) | 12 Months Ended |
Dec. 31, 2014 | |
Accounting Policies [Abstract] | |
Research and development | Research and development |
Research and development costs, including payments made to the University pursuant to the SRA, are expensed as incurred (see Note 4). | |
Stock-based compensation | Stock-based compensation |
The Company accounts for stock-based compensation arrangements for employees in accordance with Accounting Standards Codification ("ASC") No. 718, Compensation-Stock Compensation. The Company recognizes expenses for employee services received in exchange for stock based compensation based on the grant-date fair value of the shares awarded. The Company accounts for stock issued to non-employees in accordance with the provisions of ASC No. 718. | |
Incom taxes | Income taxes |
The Company accounts for income taxes in accordance with ASC No. 740, Income Taxes. This standard requires the recognition of deferred tax assets and liabilities for the estimated future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. In addition, this standard requires the recognition of future tax benefits, such as net operating loss carry forwards, to the extent that realization of such benefits is more likely than not. The amount of deferred tax liabilities or assets is calculated using tax rates in effect for the year in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rate is recognized in income in the period that includes the enactment date. Valuation allowances are established when necessary to reduce deferred tax assets to the amounts more likely than not to be realized. | |
Net loss per common share | Net loss per common share |
The Company computes net loss per share in accordance with ASC No. 260, Earnings Per Share. Under the provisions of this standard, basic net loss per common share is based on the weighted-average outstanding common shares. Diluted net loss per common share is based on the weighted-average outstanding shares adjusted for the dilutive effect of warrants to purchase common stock and convertible debentures. Due to the Company's losses, such potentially dilutive securities are anti-dilutive for all periods presented. The weighted average number of potentially dilutive shares is 42,819,990 and 33,321,337 for the years ended December 31, 2014 and 2013, respectively. | |
Use of Estimates | Use of estimates |
The preparation of financial statements in conformity with U. S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and the disclosure of contingent assets and liabilities. Actual results could differ from the estimates and assumptions used. | |
Debt issue costs | Debt issue costs |
The Company defers and amortizes the legal and filing fees associated with long-term debt that is issued. These costs are primarily related to the convertible debentures, the majority of which have a one year term. The amortization is charged to operations over the one year term and then adjusted quarterly for debenture conversions to common stock | |
Fair Value of Financial Instruments | Fair value of financial instruments |
The following methods and assumptions were used to estimate the fair value of each class of financial instrument held by the Company: | |
Current assets and current liabilities – The carrying value approximates fair value due to the short maturity of these items. | |
Debentures payable – The fair value of the Company's debentures payable has been estimated by the Company based upon the liability's characteristics, including interest rate. The carrying value approximates fair value. | |
Debentures_and_Notes_Payable_T
Debentures and Notes Payable (Tables) | 12 Months Ended | |||||||
Dec. 31, 2014 | ||||||||
Debt Disclosure [Abstract] | ||||||||
Debentures Payable | Debentures payable consist of the following: | |||||||
December 31, | December 31, | |||||||
2014 | 2013 | |||||||
Senior Convertible Debentures: | ||||||||
10% Convertible debentures to Directors due June 2015 | $ | 30,000 | $ | 30,000 | ||||
10% Convertible debenture due June 2015 | 29,007 | 29,007 | ||||||
4.75% Convertible debenture due December 2014 | 65,095 | 69,805 | ||||||
5.0% Convertible notes due 2014 (net of $498 and $19,115 OID) | 74,502 | 123,590 | ||||||
10% Convertible bridge notes due August 2015 (net of $2,813 OID) | 147,187 | - | ||||||
15% Convertible bridge notes due 2014 (net of $23,500 OID) | - | 181,500 | ||||||
Settlement Agreement 3(a)(10) | - | 118,842 | ||||||
10% Convertible bridge note to Director due December 2014 | 60,000 | 60,000 | ||||||
Total Debentures Payable | $ | 405,791 | $ | 612,744 | ||||
Common_Stock_and_PaidIn_Capita1
Common Stock and Paid-In Capital (Tables) | 12 Months Ended | |||||||
Dec. 31, 2014 | ||||||||
Common Stock, Including Additional Paid In Capital, Net Of Discount [Abstract] | ||||||||
Warrant and Option Activity | The following summary reflects warrant and option activity for the year ending December 31, 2014: | |||||||
Attached | Golden State | |||||||
Warrants | Warrants | Options | ||||||
Outstanding December 31, 2013 | 10,271,122 | 19,942 | 23,030,274 | |||||
Granted/purchased | 9,500,000 | - | - | |||||
Exercised | - | -1,347 | - | |||||
Cancelled | - | - | - | |||||
Outstanding December 31, 2014 | 19,771,122 | 18,595 | 23,030,274 | |||||
Organization_and_Operations_Ad
Organization and Operations - Additional Information (Detail) (USD $) | 12 Months Ended | 168 Months Ended | 1 Months Ended | |
Dec. 31, 2014 | Dec. 31, 2014 | Jul. 02, 2013 | Nov. 01, 2007 | |
Unusual Risk or Uncertainty [Line Items] | ||||
Net loss | ($1,253,704) | $21,258,575 | ||
Grant income | 70,748 | |||
Oklahoma Center for the Advancement of Science and Technology | ||||
Unusual Risk or Uncertainty [Line Items] | ||||
Grant income | 300,000 | |||
Golden State Debentures | ||||
Unusual Risk or Uncertainty [Line Items] | ||||
Estimated Fair Value Of Warrants | 349,310 | 349,310 | ||
4.75% Debenture due December 2015 | ||||
Unusual Risk or Uncertainty [Line Items] | ||||
Conversion or exercise cause Golden State's holdings to exceed of Company's issued and outstanding common stock | 9.99% | |||
Grant income | 34,485 | |||
4.75% Debenture due December 2015 | Golden State Debentures | ||||
Unusual Risk or Uncertainty [Line Items] | ||||
Convertible Debenture, interest rate | 4.75% | 4.75% | 4.75% | |
Receives outstanding shares upon submission of conversion notices | 1.00% | 1.00% | 1.00% | |
Warrants outstanding, exercise price | $381.50 | $381.50 | ||
Required amount of Convertible Debenture | 85.71 | |||
Warrants exercised per month | 857 | 857 | ||
Scenario, Forecast | 4.75% Debenture due December 2015 | Maximum | Golden State Debentures | ||||
Unusual Risk or Uncertainty [Line Items] | ||||
Funds from Golden State result warrant exercises | $327,000 |
Summary_of_Significant_Account2
Summary of Significant Accounting Policies - Additional Information (Detail) | 12 Months Ended | |
Dec. 31, 2014 | Dec. 31, 2013 | |
Summary Of Significant Accounting Policies [Line Items] | ||
Weighted Average Number Diluted Shares Outstanding Adjustment | 42,819,990 | 33,321,337 |
Sponsored_Research_Agreement_S1
Sponsored Research Agreement ("SRA") Common Stock Subject to Put Rights and Call Right - Additional Information (Detail) (USD $) | 0 Months Ended | 12 Months Ended | 1 Months Ended | 0 Months Ended | 1 Months Ended | |
Oct. 14, 2008 | Dec. 31, 2014 | Dec. 01, 2012 | Apr. 20, 2004 | Apr. 15, 2005 | Dec. 01, 2010 | |
Research and Development Arrangement, Contract to Perform for Others [Line Items] | ||||||
Amount paid to University of Oklahoma | $198,550 | |||||
Market Value of shares issued to University of Oklahoma for Sponsored Research Agreement | 290,000 | |||||
Proceeds from equity | 539,310 | |||||
Put Option | Second Anniversary | ||||||
Research and Development Arrangement, Contract to Perform for Others [Line Items] | ||||||
Redemption price of rights | 50,000 | |||||
Put Option | Third Anniversary | ||||||
Research and Development Arrangement, Contract to Perform for Others [Line Items] | ||||||
Redemption price of rights | 485,000 | |||||
Call Option | Third Anniversary | ||||||
Research and Development Arrangement, Contract to Perform for Others [Line Items] | ||||||
Proceeds from equity | 970,000 | |||||
Maximum | Put Option | Second Anniversary | ||||||
Research and Development Arrangement, Contract to Perform for Others [Line Items] | ||||||
Proceeds from equity | 100,000 | |||||
Maximum | Put Option | Third Anniversary | ||||||
Research and Development Arrangement, Contract to Perform for Others [Line Items] | ||||||
Proceeds from equity | 970,000 | |||||
Pilot Study to Investigate Digital Holography | ||||||
Research and Development Arrangement, Contract to Perform for Others [Line Items] | ||||||
Amount paid to University of Oklahoma | 14,116 | |||||
Investigation of 3-Dimensional Display Technologies | ||||||
Research and Development Arrangement, Contract to Perform for Others [Line Items] | ||||||
Amount paid to University of Oklahoma | 528,843 | |||||
3-Dimensional Display Development | ||||||
Research and Development Arrangement, Contract to Perform for Others [Line Items] | ||||||
Amount paid to University of Oklahoma | 525,481 | |||||
Shares issued to University of Oklahoma for Sponsored Research Agreement | 121,849 | 1,685,714 | ||||
3-Dimensional Display Development | Stock issued for cash | ||||||
Research and Development Arrangement, Contract to Perform for Others [Line Items] | ||||||
Amount paid to University of Oklahoma | $40,481 | |||||
University Of Oklahoma | ||||||
Research and Development Arrangement, Contract to Perform for Others [Line Items] | ||||||
Shares issued to University of Oklahoma for Sponsored Research Agreement | 1,807,563 |
OCAST_Grant_Additional_Informa
OCAST Grant - Additional Information (Detail) (USD $) | 12 Months Ended | ||
Dec. 31, 2014 | Dec. 31, 2013 | Sep. 01, 2013 | |
Revenue Recognition, Multiple-deliverable Arrangements [Line Items] | |||
Amount earned from grant | $70,748 | $43,896 | |
Grant receivable | $300,000 |
Consulting_Agreements_Addition
Consulting Agreements - Additional Information (Detail) (USD $) | 12 Months Ended | 1 Months Ended | 12 Months Ended | ||
Dec. 31, 2014 | Mar. 01, 2014 | Jun. 01, 2013 | Dec. 31, 2013 | Nov. 11, 2014 | |
Consulting Agreements [Line Items] | |||||
Share Based Goods And Nonemployee Services Transaction Stock Option Description | 100% of this monthly fee in registered stock at 50% discount to market; and the Company, at its option, may pay up to 50% of Concordia's monthly invoice in registered stock, at 50% discount to market, provided that the payment of stock is made within ten (10) days of receipt of invoice and further provided that the stock trades above $.30 per share at any time during the last business day of the month | ||||
Concordia Financial Group | |||||
Consulting Agreements [Line Items] | |||||
Monthly Financial Consultancy Fees | 15,750 | ||||
Financial Management Consulting Fees | 155,000 | 12,500 | 15,000 | 183,750 | |
Bayside Materials Technology | |||||
Consulting Agreements [Line Items] | |||||
Financial Management Consulting Fees | 90,244 | 0 | |||
Hourly Financial Management Consulting Fees | $176 |
Debentures_and_Notes_Payable_A
Debentures and Notes Payable - Additional Information (Detail) (USD $) | 0 Months Ended | 1 Months Ended | 12 Months Ended | 0 Months Ended | 1 Months Ended | 0 Months Ended | 12 Months Ended | 0 Months Ended | 1 Months Ended | 4 Months Ended | 1 Months Ended | |||||||||||
Sep. 03, 2014 | Jul. 26, 2013 | Dec. 31, 2014 | Dec. 31, 2013 | Oct. 01, 2013 | Jul. 02, 2014 | Aug. 15, 2014 | Dec. 31, 2012 | Jul. 03, 2012 | Apr. 30, 2013 | Sep. 11, 2012 | Aug. 24, 2012 | Aug. 28, 2012 | Mar. 21, 2013 | Dec. 21, 2012 | Nov. 03, 2006 | Jul. 01, 2014 | Dec. 20, 2012 | Jun. 24, 2013 | Aug. 01, 2012 | Jan. 26, 2013 | Jun. 26, 2013 | |
Debt Conversion [Line Items] | ||||||||||||||||||||||
Convertible debenture, amount converted | $336,552 | $568,828 | ||||||||||||||||||||
Accounts payable | 197,631 | |||||||||||||||||||||
Stock issued during period shares other | 650,000 | |||||||||||||||||||||
Conversion rate to closing bid price | 65.00% | |||||||||||||||||||||
Conversion closing bid price | $1 | $0.00 | ||||||||||||||||||||
Warrant | ||||||||||||||||||||||
Debt Conversion [Line Items] | ||||||||||||||||||||||
Warrants outstanding, exercise price | $0.01 | |||||||||||||||||||||
Estimated Fair Value Of Warrants | 2,130 | |||||||||||||||||||||
Fair Value Assumptions, Expected Volatility Rate | 173.64% | |||||||||||||||||||||
Fair Value Assumptions, Risk Free Interest Rate | 1.39% | |||||||||||||||||||||
Fair Value Assumptions, Expected Dividend Rate | 0.00% | |||||||||||||||||||||
Fair Value Assumptions, Expected Term | 5 years | |||||||||||||||||||||
Settlement Agreement | ||||||||||||||||||||||
Debt Conversion [Line Items] | ||||||||||||||||||||||
Convertible debt, principal amount | 78,789 | |||||||||||||||||||||
Convertible note, conversion price | $0.00 | |||||||||||||||||||||
Warrants outstanding, exercise price | $6,810,811 | |||||||||||||||||||||
Shares of common stock issuable under registration statement | 9,000,000 | |||||||||||||||||||||
Stock issued during period, shares, conversion of units | 53,720,000 | |||||||||||||||||||||
Remaining balance paid in cash | 190,000 | |||||||||||||||||||||
10% Convertible debenture due June 2014 | ||||||||||||||||||||||
Debt Conversion [Line Items] | ||||||||||||||||||||||
Convertible debt net | 29,007 | 29,007 | ||||||||||||||||||||
4.75% Debenture due in December 31, 2014 | ||||||||||||||||||||||
Debt Conversion [Line Items] | ||||||||||||||||||||||
Convertible debt, principal amount | 100,000 | |||||||||||||||||||||
Convertible note, conversion price | $0.70 | |||||||||||||||||||||
Convertible note, conversion description | The conversion price for the 4.75% $100,000 convertible debenture is the lesser of (i)$140 or (ii) 80% of the average of the five lowest volume weighted average prices during the twenty (20) trading days prior to the conversion. | |||||||||||||||||||||
Advances on Debenture | 100,000 | |||||||||||||||||||||
Convertible debenture, amount converted | 4,710 | |||||||||||||||||||||
Conversion of convertible debenture, shares issued | 98,093,643 | |||||||||||||||||||||
Debenture, prepay portion in percentage | 135.00% | |||||||||||||||||||||
Warrants to purchase common stock, issued | 28,571 | |||||||||||||||||||||
Warrants outstanding, exercise price | $381.50 | $381.50 | ||||||||||||||||||||
Exercise of warrants to purchase common stock | 1,347 | |||||||||||||||||||||
Advance against future exercise of warrants | 349,310 | |||||||||||||||||||||
Convertible debt net | 65,095 | 69,805 | ||||||||||||||||||||
4.75% Debenture due in December 31, 2014 | Applied to the exercise of warrants | ||||||||||||||||||||||
Debt Conversion [Line Items] | ||||||||||||||||||||||
Advance against future exercise of warrants | 513,390 | |||||||||||||||||||||
4.75% Debenture due in December 31, 2014 | If volume weighted average price is below $0.70 | ||||||||||||||||||||||
Debt Conversion [Line Items] | ||||||||||||||||||||||
Debenture, prepay portion in percentage | 135.00% | |||||||||||||||||||||
4.75% Debenture due in December 31, 2014 | Golden State | ||||||||||||||||||||||
Debt Conversion [Line Items] | ||||||||||||||||||||||
Advances on Debenture | 100,000 | |||||||||||||||||||||
Convertible debenture, amount converted | 3,860 | |||||||||||||||||||||
Conversion of convertible debenture, shares issued | 37,651,544 | |||||||||||||||||||||
Warrants outstanding, exercise price | $381.50 | |||||||||||||||||||||
Exercise of warrants to purchase common stock | 1,103 | |||||||||||||||||||||
Advance against future exercise of warrants | 671,810 | |||||||||||||||||||||
4.75% Debenture due in December 31, 2014 | Golden State | Applied to the exercise of warrants | ||||||||||||||||||||||
Debt Conversion [Line Items] | ||||||||||||||||||||||
Advance against future exercise of warrants | 420,740 | |||||||||||||||||||||
4.75% Debenture due in December 31, 2014 | Golden State | Unapplied advances | ||||||||||||||||||||||
Debt Conversion [Line Items] | ||||||||||||||||||||||
Advance against future exercise of warrants | 21,591 | 185,671 | ||||||||||||||||||||
5% Convertible Promissory Note | ||||||||||||||||||||||
Debt Conversion [Line Items] | ||||||||||||||||||||||
Convertible debt net | 498 | 19,115 | ||||||||||||||||||||
15% Convertible Bridge Notes | ||||||||||||||||||||||
Debt Conversion [Line Items] | ||||||||||||||||||||||
Convertible debt, principal amount | 205,000 | |||||||||||||||||||||
Warrants to purchase common stock, issued | 300,000 | |||||||||||||||||||||
Original issue discount | 30,750 | |||||||||||||||||||||
Legal And Documentation Fees | 22,500 | |||||||||||||||||||||
Placement Agent Fees | 15,682 | |||||||||||||||||||||
Convertible Debenture, interest rate | 15.00% | |||||||||||||||||||||
Proceeds from notes payable | 174,250 | |||||||||||||||||||||
Remaining balance paid in cash | 25,000 | |||||||||||||||||||||
Convertible debt net | 23,500 | |||||||||||||||||||||
Percentage Of Volume Weighted Average Price | 100.00% | |||||||||||||||||||||
Newton O Connor Turner And Ketchum 10% Convertible Debenture | ||||||||||||||||||||||
Debt Conversion [Line Items] | ||||||||||||||||||||||
Convertible debt, principal amount | 29,007 | |||||||||||||||||||||
Convertible note, conversion price | $0.03 | |||||||||||||||||||||
Victor Keen and Martin Keating 10% convertible debenture | ||||||||||||||||||||||
Debt Conversion [Line Items] | ||||||||||||||||||||||
Convertible debt, principal amount | 15,000 | |||||||||||||||||||||
Convertible note, conversion price | $0.01 | |||||||||||||||||||||
15% Convertible Promissory Note One | ||||||||||||||||||||||
Debt Conversion [Line Items] | ||||||||||||||||||||||
Convertible debenture, amount converted | 180,000 | |||||||||||||||||||||
Conversion of convertible debenture, shares issued | 83,705,721 | |||||||||||||||||||||
Debt Conversion, Description | Pursuant to the SSA, the Investor agreed to extend the maturity of the $205,000 principal owed (the Debt) under the Senior Note until August 15, 2015 and the Company agreed, among other things, to (i) pay 10% interest on the Debt; (ii) pay 125% of principal in the event the Company elects to prepay any portion of the Debt; (iii) allow the Investor to convert the Debt, in whole or in part, into shares of the Companys common stock at a conversion price equal to 58% percent of the lowest traded VWAP, determined on the then current trading market for the Companys common stock, for the 15 trading days prior to conversion. | |||||||||||||||||||||
Debt Conversion Converted Instrument Average Price Per Share | $0.00 | |||||||||||||||||||||
5% Convertible Bridge Notes | ||||||||||||||||||||||
Debt Conversion [Line Items] | ||||||||||||||||||||||
Convertible debt, principal amount | 415,000 | |||||||||||||||||||||
Convertible note, conversion description | In addition to the OID, the 5% Notes provides for a one-time interest charge of 5% to be applied to the principal sum advanced. Pursuant to the terms of 5% Notes, JMJ may, at its election, convert all or a part of the $275,000 note and the $140,000 note into shares of the Company's common stock at a conversion rate equal to the lesser of (i) $0.15 and $0.35, respectively or (ii) 70% of the lowest trade price during the twenty-five trading days prior to JMJ’s election to convert. If the Company repays the 5% Notes on or before ninety days from the date it was issued, the interest rate will be zero percent. If the Company does not repay the 5% Notes on or before ninety days from the date it was issued, a one-time interest charge of 5% shall be applied to the principal. The Company did not repay the 5% Notes within the ninety day period. The principal of the 5% Notes is due one year from the date of each of the principal amounts advanced. | |||||||||||||||||||||
Advances on Debenture | 75,000 | 120,000 | 150,000 | |||||||||||||||||||
Convertible debenture, amount converted | 203,700 | |||||||||||||||||||||
Conversion of convertible debenture, shares issued | 31,854,924 | |||||||||||||||||||||
Warrants outstanding, exercise price | $0.00 | |||||||||||||||||||||
Original issue discount | 40,000 | |||||||||||||||||||||
Original issue discount collected | 5,975 | 32,205 | 14,000 | |||||||||||||||||||
Conversion of convertible debentures into common stock | 148,680 | |||||||||||||||||||||
Conversion of convertible debentures into common stock, shares | 47,848,529 | |||||||||||||||||||||
Convertible debenture, conversion price per share | $0.01 | |||||||||||||||||||||
5% Convertible Bridge Notes Two | ||||||||||||||||||||||
Debt Conversion [Line Items] | ||||||||||||||||||||||
Shares of common stock issuable under registration statement | 4,750,000 | |||||||||||||||||||||
Legal And Documentation Fees | 25,000 | |||||||||||||||||||||
10% Convertible Bridge Note | ||||||||||||||||||||||
Debt Conversion [Line Items] | ||||||||||||||||||||||
Convertible note, conversion description | Upon maturity of the Bridge Notes, the holders of the Bridge Notes may elect to convert all or any portion of the outstanding principal amount of the Bridge Notes into (i) securities sold pursuant to an effective registration statement at the applicable offering price; or (ii) shares of common stock at a conversion price equal to the lesser of 100% of the Volume Weighted Average Price (VWAP), as reported for the 5 trading days prior to (a) the date of issuance of the Bridge Notes, (b) the maturity date of the Bridge Notes, or (c) the first closing date of the securities sold pursuant an effective registration statement. | |||||||||||||||||||||
Legal And Documentation Fees | 25,000 | |||||||||||||||||||||
Placement Agent Fees | 27,675 | |||||||||||||||||||||
Convertible Debenture, interest rate | 15.00% | |||||||||||||||||||||
Proceeds from notes payable | 365,000 | |||||||||||||||||||||
Conversion of convertible debentures into common stock | 78,000 | |||||||||||||||||||||
Conversion of convertible debentures into common stock, shares | 2,025,974 | |||||||||||||||||||||
Convertible debt net | 2,813 | |||||||||||||||||||||
Debt Instrument, Maturity Date | 22-Nov-12 | |||||||||||||||||||||
Debt instrument aggregate principal amount | 60,000 | 438,000 | ||||||||||||||||||||
Debt Instrument, Unamortized Discount | 73,000 | |||||||||||||||||||||
10% Convertible Bridge Note | Before Amendment | ||||||||||||||||||||||
Debt Conversion [Line Items] | ||||||||||||||||||||||
Convertible debt, principal amount | 300,000 | |||||||||||||||||||||
Debt Instrument Convertible Shares Of Equity Instruments | 5,172,414 | |||||||||||||||||||||
10% Convertible Bridge Note | After Amendment | ||||||||||||||||||||||
Debt Conversion [Line Items] | ||||||||||||||||||||||
Convertible debt, principal amount | 325,000 | |||||||||||||||||||||
Convertible note, conversion price | $0.04 | |||||||||||||||||||||
Percentage Of Volume Weighted Average Price | 100.00% | |||||||||||||||||||||
Debt Instrument Convertible Shares Of Equity Instruments | 8,000,000 | |||||||||||||||||||||
Debt Instrument, Fee Amount | 20,000 | |||||||||||||||||||||
10% Convertible Bridge Note | George Widener | ||||||||||||||||||||||
Debt Conversion [Line Items] | ||||||||||||||||||||||
Debt instrument aggregate principal amount | 78,000 | |||||||||||||||||||||
10% Convertible Bridge Note | Victor Keen | ||||||||||||||||||||||
Debt Conversion [Line Items] | ||||||||||||||||||||||
Convertible debt, principal amount | 60,000 | |||||||||||||||||||||
10% Convertible Bridge Note | Widener Amendment | ||||||||||||||||||||||
Debt Conversion [Line Items] | ||||||||||||||||||||||
Convertible debt, principal amount | 78,000 | |||||||||||||||||||||
10% Convertible Debenture due August 2015 | ||||||||||||||||||||||
Debt Conversion [Line Items] | ||||||||||||||||||||||
Convertible debt, principal amount | 150,000 | |||||||||||||||||||||
Advances on Debenture | 145,500 | |||||||||||||||||||||
Legal And Documentation Fees | 5,000 | |||||||||||||||||||||
Convertible debt net | 147,187 | 0 | ||||||||||||||||||||
Debt Instrument Convertible Beneficial Ownership Limitation Percentage | 4.99% | |||||||||||||||||||||
GCASIF Amendement | 10% Convertible Bridge Note | ||||||||||||||||||||||
Debt Conversion [Line Items] | ||||||||||||||||||||||
Convertible debt, principal amount | 204,480 | |||||||||||||||||||||
Convertible note, conversion price | $0.00 | |||||||||||||||||||||
Conversion of convertible debenture, shares issued | 48,811,800 | |||||||||||||||||||||
Remaining balance paid in cash | 120,520 | |||||||||||||||||||||
Debt instrument aggregate principal amount | $300,000 |
Debentures_and_Notes_Payable_D
Debentures and Notes Payable (Detail) (USD $) | Dec. 31, 2014 | Dec. 31, 2013 |
Debt Instrument [Line Items] | ||
Total Long-term Debentures Payable | $405,791 | $612,744 |
10% Convertible debentures to Directors due June 2015 | ||
Debt Instrument [Line Items] | ||
Total Debentures | 30,000 | 30,000 |
10% Convertible debenture due June 2015 | ||
Debt Instrument [Line Items] | ||
Total Debentures | 29,007 | 29,007 |
4.75% Convertible debenture due December 2014 | ||
Debt Instrument [Line Items] | ||
Total Debentures | 65,095 | 69,805 |
5.0% Convertible notes due 2014 (net of $498 and $19,115 OID) | ||
Debt Instrument [Line Items] | ||
Total Debentures | 74,502 | 123,590 |
15% Senior Convertible bridge notes due 2014 | ||
Debt Instrument [Line Items] | ||
Total Debentures | 23,500 | |
Settlement Agreement 3(a)(10) | ||
Debt Instrument [Line Items] | ||
Total Debentures | 0 | 118,842 |
15% Convertible bridge notes due 2014 | ||
Debt Instrument [Line Items] | ||
Total Debentures | 0 | 181,500 |
10% Convertible bridge note to Director due December 2014 | ||
Debt Instrument [Line Items] | ||
Total Debentures | 60,000 | 60,000 |
10% Convertible bridge notes due August 2015 | ||
Debt Instrument [Line Items] | ||
Total Debentures | $147,187 | $0 |
Common_Stock_and_PaidIn_Capita2
Common Stock and Paid-In Capital - Additional Information (Detail) (USD $) | 0 Months Ended | 1 Months Ended | 0 Months Ended | 1 Months Ended | 0 Months Ended | 12 Months Ended | 0 Months Ended | 3 Months Ended | 0 Months Ended | ||||||
Sep. 03, 2014 | Oct. 14, 2008 | Jan. 23, 2014 | Dec. 09, 2013 | Dec. 11, 2013 | Jul. 26, 2013 | Apr. 11, 2013 | Dec. 31, 2014 | Dec. 31, 2013 | Mar. 13, 2012 | Dec. 31, 2012 | Sep. 30, 2012 | Jun. 30, 2012 | Mar. 16, 2012 | Mar. 31, 2012 | |
Conversion Of Stock [Line Items] | |||||||||||||||
Stock issued for consulting services, value | $290,000 | ||||||||||||||
Share-based compensation arrangement by share-based payment award, options, grants in period, gross | 10,000,000 | ||||||||||||||
Maximum purchase of restricted common shares | 10,000,000 | ||||||||||||||
Maximum purchase of restricted common shares purchase price per share | $0.01 | ||||||||||||||
Gross proceeds from options agreements | 100,000 | ||||||||||||||
Payments for repurchase of private placement | 195,000 | 195,000 | |||||||||||||
Common Stock for gross proceed | 195,000 | ||||||||||||||
Warrants to purchase of common stock | 50 | ||||||||||||||
Purchase price per share | $1 | ||||||||||||||
Proceeds from issuance of private placement | 195,000 | 195,000 | |||||||||||||
Preferred Stock, Shares Authorized | 500,000 | 500,000 | |||||||||||||
Preferred Stock, Par or Stated Value Per Share | $0.00 | 0.0002 | |||||||||||||
Conversion Price Of Stock | $0.05 | ||||||||||||||
Stock Issued During Period, Value, Conversion of Convertible Securities | 190,000 | ||||||||||||||
Options granted | 10,000,000 | ||||||||||||||
Conversion Closing Bid Price | $1 | $0.00 | |||||||||||||
Private Placement | |||||||||||||||
Conversion Of Stock [Line Items] | |||||||||||||||
Stock Issued During Period Shares Conversion Of Convertible Securities | 190,000 | ||||||||||||||
Total purchase price of the securities sold | 385,000 | ||||||||||||||
Warrant | |||||||||||||||
Conversion Of Stock [Line Items] | |||||||||||||||
Warrants outstanding, exercise price | $0.01 | ||||||||||||||
Stock issued for consulting services, shares | 9,750,000 | ||||||||||||||
Estimated fair value of options | 27,000 | ||||||||||||||
Expected dividend yield | 0 | ||||||||||||||
Expected volatility | 178.00% | ||||||||||||||
Risk-free interest | 1.38% | ||||||||||||||
Expected life of option | 5 years | ||||||||||||||
Warrants to purchase of common stock | 50 | ||||||||||||||
Common stock outstanding percentage | 4.99% | ||||||||||||||
Warrant | Investor | |||||||||||||||
Conversion Of Stock [Line Items] | |||||||||||||||
Common stock outstanding percentage | 9.99% | ||||||||||||||
Common Stock | |||||||||||||||
Conversion Of Stock [Line Items] | |||||||||||||||
Stock Issued During Period Shares Conversion Of Convertible Securities | 50,000,000 | ||||||||||||||
Series A Convertible Preferred Stock | |||||||||||||||
Conversion Of Stock [Line Items] | |||||||||||||||
Preferred Stock, Shares Authorized | 195,000 | 195,000 | 500,000 | ||||||||||||
Preferred Stock, Par or Stated Value Per Share | $0.00 | ||||||||||||||
Preferred Stock, Dividend Rate, Percentage | 6.00% | ||||||||||||||
Group Two | |||||||||||||||
Conversion Of Stock [Line Items] | |||||||||||||||
Warrants outstanding | 125,098 | ||||||||||||||
Group Two | Expire on Sep 30, 2016 | |||||||||||||||
Conversion Of Stock [Line Items] | |||||||||||||||
Warrants outstanding, exercise price | $3.15 | ||||||||||||||
Group Three | |||||||||||||||
Conversion Of Stock [Line Items] | |||||||||||||||
Warrants outstanding | 96,024 | ||||||||||||||
Group Three | Expire on June 1, 2015 | |||||||||||||||
Conversion Of Stock [Line Items] | |||||||||||||||
Warrants outstanding, exercise price | $3.15 | ||||||||||||||
Group Four | |||||||||||||||
Conversion Of Stock [Line Items] | |||||||||||||||
Warrants outstanding | 18,595 | ||||||||||||||
Group Four | Expire on December 31,2014 | |||||||||||||||
Conversion Of Stock [Line Items] | |||||||||||||||
Warrants outstanding, exercise price | $381.50 | ||||||||||||||
Group Five | |||||||||||||||
Conversion Of Stock [Line Items] | |||||||||||||||
Warrants outstanding | 300,000 | ||||||||||||||
Group Five | March 31, 2019 | |||||||||||||||
Conversion Of Stock [Line Items] | |||||||||||||||
Warrants outstanding, exercise price | $0.00 | ||||||||||||||
Group Six | |||||||||||||||
Conversion Of Stock [Line Items] | |||||||||||||||
Warrants outstanding | 9,750,000 | ||||||||||||||
Group Six | December 31, 2017 | |||||||||||||||
Conversion Of Stock [Line Items] | |||||||||||||||
Warrants outstanding, exercise price | $0.01 | ||||||||||||||
Group Seven | |||||||||||||||
Conversion Of Stock [Line Items] | |||||||||||||||
Warrants outstanding | 9,500,000 | ||||||||||||||
Stock issued for services | Common Stock | |||||||||||||||
Conversion Of Stock [Line Items] | |||||||||||||||
Stock issued for consulting services, shares | 28,205,571 | 25,892,479 | |||||||||||||
Consulting Services | |||||||||||||||
Conversion Of Stock [Line Items] | |||||||||||||||
Stock issued for consulting services, value | 108,500 | 295,350 | |||||||||||||
Common stock issued to consultants for previous services provided | 13,131,828 | 1,098,751 | |||||||||||||
Reduction in accounts payable liability | 6,267 | 31,500 | |||||||||||||
Mark Willner | |||||||||||||||
Conversion Of Stock [Line Items] | |||||||||||||||
Share-based compensation arrangement by share-based payment award, options, grants in period, gross | 57,143 | ||||||||||||||
Employment agreement, terms effective period | 1 year | ||||||||||||||
Annual Base Salary | 180,000 | ||||||||||||||
Stock options granted, term | 5 years | ||||||||||||||
Options granted | 57,143 | ||||||||||||||
Stock option plan, exercise price | $0.35 | ||||||||||||||
Employment agreement, termination period | 60 days | ||||||||||||||
Mark Willner | Employee Stock Option | |||||||||||||||
Conversion Of Stock [Line Items] | |||||||||||||||
Stock issued for consulting services, value | 0 | ||||||||||||||
Estimated fair value of options | 18,840 | 18,840 | 18,840 | 18,840 | |||||||||||
Expected volatility | 163.00% | ||||||||||||||
Risk-free interest | 1.87% | ||||||||||||||
Expected life of option | 5 years | ||||||||||||||
Mark Willner | Scenario, Forecast | |||||||||||||||
Conversion Of Stock [Line Items] | |||||||||||||||
Additional Stock option plan, shares granted | 28,571.50 | 28,571.50 | 28,571.50 | ||||||||||||
George Melnik | |||||||||||||||
Conversion Of Stock [Line Items] | |||||||||||||||
Share-based compensation arrangement by share-based payment award, options, grants in period, gross | 28,571.50 | 28,571 | |||||||||||||
Employment agreement, terms effective period | 1 year | ||||||||||||||
Annual Base Salary | 144,000 | ||||||||||||||
Stock options granted, term | 5 years | ||||||||||||||
Options granted | 28,571.50 | 28,571 | |||||||||||||
Stock option plan, exercise price | $0.35 | ||||||||||||||
Employment agreement, termination period | 60 days | ||||||||||||||
George Melnik | Employee Stock Option | |||||||||||||||
Conversion Of Stock [Line Items] | |||||||||||||||
Reduction in accounts payable liability | 28,571 | 28,571 | 28,571 | ||||||||||||
Estimated fair value of options | 9,420 | 9,420 | 9,420 | 9,420 | |||||||||||
Expected dividend yield | $0 | ||||||||||||||
Expected volatility | 163.00% | ||||||||||||||
Risk-free interest | 1.87% | ||||||||||||||
Expected life of option | 5 years |
Warrant_and_Option_Activity_De
Warrant and Option Activity (Detail) | 12 Months Ended |
Dec. 31, 2014 | |
Attached Warrants | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Outstanding beginning of period | 10,271,122 |
Granted/purchased | 9,500,000 |
Exercised | 0 |
Cancelled | 0 |
Outstanding at end of period | 19,771,122 |
Golden State Warrants | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Outstanding beginning of period | 19,942 |
Granted/purchased | 0 |
Exercised | -1,347 |
Cancelled | 0 |
Outstanding at end of period | 18,595 |
Options | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Outstanding beginning of period | 23,030,274 |
Granted/purchased | 0 |
Exercised | 0 |
Cancelled | 0 |
Outstanding at end of period | 23,030,274 |
Incentive_Stock_Plan_Additiona
Incentive Stock Plan - Additional Information (Detail) | 12 Months Ended | ||
Dec. 31, 2014 | Jun. 30, 2013 | Mar. 31, 2014 | |
2013 Equity Incentive Plan | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Incentive stock plan, authorized | -20,000,000 | ||
Incentive stock plan, issued | 20,000,000 | ||
Incentive stock plan, shares available for issuance | 0 | ||
2014 Equity Incentive Plan | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Incentive stock plan, authorized | -50,000,000 | ||
Incentive stock plan, issued | 42,456,419 | ||
Incentive stock plan, shares available for issuance | 7,543,581 |
Office_Lease_Additional_Inform
Office Lease - Additional Information (Detail) (USD $) | 12 Months Ended | 0 Months Ended | 1 Months Ended |
Dec. 31, 2014 | Mar. 08, 2011 | Jul. 24, 2012 | |
Lease agreement signed date | 24-Apr-08 | ||
Lease agreement commencement date | 1-Jun-08 | ||
Lease expiration date | 1-Jun-11 | ||
Lease Agreements Future Minimum Payments Due | $13,000 | ||
First Amendment | |||
Extended lease expiration date | 31-May-12 | ||
Second Amendment | |||
Extended lease expiration date | 31-Jul-15 |
Related_Party_Transaction_Addi
Related Party Transaction - Additional Information (Detail) (Newton, O'Connor, Turner & Ketchum, a professional corporation ("NOTK"), USD $) | 12 Months Ended | |
Dec. 31, 2014 | Dec. 31, 2013 | |
Newton, O'Connor, Turner & Ketchum, a professional corporation ("NOTK") | ||
Related Party Transaction [Line Items] | ||
Legal fees incurred to Newton | $3,360 | $23,137 |
Subsequent_Events_Additional_I
Subsequent Events - Additional Information (Detail) (USD $) | 1 Months Ended | 0 Months Ended | 12 Months Ended | 1 Months Ended | 12 Months Ended | ||
Jul. 26, 2013 | Apr. 11, 2013 | Dec. 31, 2014 | Dec. 31, 2013 | Mar. 31, 2015 | Dec. 31, 2015 | Mar. 31, 2014 | |
Subsequent Event [Line Items] | |||||||
Stock Issued During Period Shares Other | 650,000 | ||||||
Expense recognized for common stock shares issued for services | $108,500 | $295,350 | |||||
Incentive stock plan, issued | 10,000,000 | ||||||
Increase Decrease In Accounts Payable and Accrued Liabilities | 420,911 | 46,327 | |||||
4.75% Convertible Debenture | |||||||
Subsequent Event [Line Items] | |||||||
Number of warrants exercised | 114 | ||||||
Warrants exercise price per share | $381.50 | ||||||
Advance payment for future exercise of warrants | 10,900 | ||||||
Stock Issued During Period Value Stock Warrants Exercised | 43,545 | ||||||
Convertible note, conversion price | $0.00 | ||||||
Debt Conversion Converted Instrument Amount 1 | 400 | ||||||
Debt Conversion Converted Instrument Shares Issued 1 | 18,727,884 | ||||||
2014 Equity Incentive Plan | |||||||
Subsequent Event [Line Items] | |||||||
Incentive stock plan, authorized | 50,000,000 | ||||||
Incentive stock plan, issued | 6,793,478 | ||||||
Incentive stock plan, shares available for issuance | 7,543,581 | ||||||
Increase Decrease In Accounts Payable and Accrued Liabilities | 12,500 | ||||||
Incentive stock plan, Remaining shares available for issuance | 750,103 | ||||||
2015 Equity Incentive Plan | |||||||
Subsequent Event [Line Items] | |||||||
Incentive stock plan, authorized | 85,000,000 | ||||||
Incentive stock plan, issued | 23,223,684 | ||||||
Incentive stock plan, shares available for issuance | 61,776,316 | ||||||
Stock Issued During Period, Value, Issued for Services | 35,000 | ||||||
Subsequent Event | 10% Convertible Promissory Note | |||||||
Subsequent Event [Line Items] | |||||||
Convertible note, conversion price | $0.00 | ||||||
Conversion Of Convertible Debentures Into Common Stock Value | 25,000 | ||||||
Conversion Of Convertible Debentures Into Common Stock Shares | 14,245,014 | ||||||
Subsequent Event | JMJ March 2015 5% Note | |||||||
Subsequent Event [Line Items] | |||||||
Debt Instrument Face Amount | 250,000 | ||||||
Debt Instrument Original Issue Discount | 25,000 | ||||||
Proceeds from Convertible Debt | 30,000 | ||||||
Accretion Of Original Issue Discount | 3,000 | ||||||
Debt Instrument Convertible Terms Of Conversion Feature | In addition to the OID, the March 2015 5% Note provides for a one-time interest charge of 5% to be applied to the Principal Sum. If the Company repays the 5% Note on or before ninety days from the date of the principal amount advanced, the interest rate will be zero percent. If the Company does not repay the March 2015 5% Note on or before ninety days from the date of the advance, a one-time interest charge of 5% shall be applied to the Principal Sum. Pursuant to the terms of March 2015 5% Note, JMJ may, at its election, convert all or a part of the $250,000 note into shares of the Company's common stock at a conversion rate 70% of the lowest trade price during the twenty-five trading days prior to JMJs election to convert. The principal of the March 2015 5% Note is due two years from the date of each of the principal amounts advanced. | ||||||
Subsequent Event | Typenex Co-Investment, LLC | |||||||
Subsequent Event [Line Items] | |||||||
Debt Instrument Face Amount | 87,500 | ||||||
Debt Instrument Original Issue Discount | 7,500 | ||||||
Proceeds From Notes Payable | 80,000 | ||||||
Legal Fees | 20,000 | ||||||
Placement Agent Fees | 6,750 | ||||||
Debt Instrument Convertible Terms Of Conversion Feature | In addition to the OID, the 5% Promissory Note provides for a one-time interest charge of 5% to be applied to the principal of the 5% Promissory Note. If the Company repays the 5% Promissory Note on or before ninety days from the date of the principal amount advanced, the interest rate will be zero percent. If the Company does not repay the 5% Promissory Note on or before ninety days from the date of the advance, a one-time interest charge of 5% shall be applied to the Principal Sum. Pursuant to the terms of 5% Promissory Note, Typenex may, at its election, convert all or a part of the $87,500 principal and interest thereon of the 5% Promissory Note into shares of the Company's common stock at a conversion rate 70% of the lowest trade price during the twenty-five trading days prior to the election to convert. The principal of the 5% Promissory Note is due one year from the March 2015 effective date. | ||||||
Subsequent Event | Consulting Services | |||||||
Subsequent Event [Line Items] | |||||||
Stock Issued During Period Shares Other | 15,017,162 | ||||||
Expense recognized for common stock shares issued for services | 25,000 | ||||||
Subsequent Event | Legal Services | |||||||
Subsequent Event [Line Items] | |||||||
Stock Issued During Period Shares Other | 15,000,000 | ||||||
Expense recognized for common stock shares issued for services | 22,500 | ||||||
Subsequent Event | JMJ Converted | |||||||
Subsequent Event [Line Items] | |||||||
Convertible note, conversion price | $0.00 | ||||||
Conversion Of Convertible Debentures Into Common Stock Value | $17,500 | ||||||
Conversion Of Convertible Debentures Into Common Stock Shares | 10,000,000 |